International Longevity Day – October 1, 2015

International Longevvity DayDear friends,

There has been emerging a tradition by longevity researchers and activists around the world to organize events dedicated to promotion of longevity research on or around October 1 – the UN International Day of Older Persons.

This day is sometimes referred to in some parts of the longevity activists community as the “International Longevity Day”. As this is the official UN Day of Older Persons, this provides the longevity research activists a perfect opportunity, perhaps even a perfect “excuse”, to emphasize the importance of aging and longevity research for the development of effective health care for the elderly, in the wide public as well as among decision makers.

The critical importance and the critical need to promote biological research of aging derives from the realization that tackling the degenerative processes and negative biological effects of human aging, at once and in an interrelated manner, can provide the best foundations to find holistic and effective ways for intervention and prevention against age-related ill health. Such an approach has been supported by scientific proofs of concept, involving the evidential increase in healthy lifespan in animal models and the emerging technological capabilities to intervene into fundamental aging processes. The focus on intervention into degenerative aging processes can provide solutions to a number of non-communicable, age-related diseases (such as cancer, heart disease, type 2 diabetes and neurodegenerative diseases), insofar as such diseases are strongly determined by degenerative aging processes (such as chronic inflammation, cross-linkage of macromolecules, somatic mutations, loss of stem cell populations, and others). This approach is likely to decrease susceptibility of the elderly also to communicable, infectious diseases due to improvements in immunity. The innovative, applied results of such research and development will lead to sustainable, economically viable solutions for a large array of age-related medical and social challenges, that may be globally applicable. Furthermore, such research and development should be supported on ethical grounds, to provide equal health care chances for the elderly as for the young.

Therefore it is the societal duty, especially of the professionals in biology, medicine, health care, economy and socio-political organizations, to strongly recommend greater investments, incentives and institutional support for the research and development dealing with the understanding of mechanisms associated with the human biological aging process and translating these insights into safe, affordable and universally available applied technologies and treatments.

October 1 – the International Day of Older Persons — provides the researchers and advocates an opportunity to raise these points and make these demands.

http://www.longevityforall.org/the-critical-need-to-promote-research-of-aging-around-the-world/

In 2013, events during or around that day – ranging from small meetings of friends to seminars and rather large conferences, alongside special publications, distributions of outreach materials (petitions and flyers) and media appearances – were held in over 30 countries, and in 2014 in over 20 countries.

Sometimes the events’ dates vary several days around October 1, or even through the entire month of October, designated as the “International Month of Older Persons” or the “International Longevity Month”, and sometimes the events are organized independently and without prior knowledge of other events, but they are all nonetheless unified by the common action and purpose.

http://www.longevityforall.org/october-1-international-day-of-older-persons-longevity-day-2013-2014/

Let us maintain and strengthen this tradition! Let us plan and organize a mutually reinforcing network of events worldwide. If you plan to organize an event for that day or month – either live meetings or on-line publications and promotions – please let your plans be known to encourage others. Together we can create an activism wave of strong impact. 

Among the materials for discussion, distribution and promotion, one may use the position paper on the “Critical need to promote research of aging and aging-related diseases to improve health and longevity of the elderly population”, briefly describing the rationales, technologies and policies needed to promote this research. The position paper is available in 9 languages and can serve as a “universal advocacy paper” both for the grass roots discussions and promotions and for the outreach to officials http://www.longevityforall.org/the-critical-need-to-promote-research-of-aging-around-the-world/. Also one may use in the preparation a presentation briefly listing some topics in longevity science promotion, such as the feasibility and desirability of achieving healthy longevity and public actions that can be taken to achieve it http://www.longevityhistory.com/articles/ab7.php . One may also consider using or modifying the following template flyers, from the Longevity Day campaigns of 2013 Longevity Day – Flyer Template – 2013 and the present 2015 Longevity Day – Flyer Template – 2015 or any other materials of your choice.

For the Longevity Day and Month celebrations in 2015, following the collection of a number of longevity promoting events worldwide in honor of that day, a general public appeal was issued and widely disseminated.

Among others, this campaign was endorsed by several prominent associations for the advancement of aging research, including:

International Association of Gerontology and Geriatrics – European Region – IAGG-ER (http://www.iagg-er.net/) as well as the international IAGG Secretariat http://iagg.info/xe/iagg_news/14762 ; http://iagg.info/data/newsletter_v20/newsletter_20-08_2015.pdf ; the International Federation on Ageing (IFA) http://www.ifa-fiv.org/idop-celebrates-longevity/ ; the US Healthspan Campaign http://healthspancampaign.org/newsletters/august-2015/ ; http://healthspancampaign.org/newsletters/september-2015/  ; Alliance for Aging Research http://www.agingresearch.org ; International Society on Aging and Disease http://isoad.org ; JenAge http://info-centre.jenage.de/ageing/meetings-calendar.html  ; SENS Research Foundation http://www.sens.org/ ; Maximum Life Foundation http://www.maxlife.org/ ; Institute for Ethics and Emerging Technologies http://ieet.org/index.php/IEET/more/stambler20150831  ; Fight Aging https://www.fightaging.org/archives/2015/09/october-1st-is-international-longevity-day-events-are-planned.php ; Humanity+ http://hplusmagazine.com/2015/10/01/longevity-day-2015/  ; World Future Society https://www.facebook.com/World-Future-Society ; national gerontological associations in several countries.

Yet, the strength of the appeal depends on the strength of all the individual events and actions.

Events for that day – including meetings, publications and promotions – have been organized around the world, in over 40 countries on 5 continents, including:

1. In the US, a conference was held at the headquarters of the International Society on Aging and Disease (ISOAD), at the University of North Texas Health Science Center, in Fort Worth, Texas (http://isoad.org/).  Also in the US, video conferences were held by the Movement for Indefinite Life Extension (MILE ) campaign and by the Christian Transhumanist Association (CTI).

A special promotion was done by LEAF – Life Extension Advocacy Foundation – via its crowdfunding platform for longevity research (http://www.lifespan.io/). A fundraising action was launched on that day for SENS Research Foundation by Fight Aging (https://www.fightaging.org/fund-research/).

2. In Israel, a seminar was held in Bar Ilan University, by the Israeli Longevity Alliance. Further outreach was done in schools and via dedicated publications. Toward that day, Israeli activists also freely distributed an e-book on the history of longevity research (http://www.longevityhistory.com/).

3. In Moscow, Russia, a conference was organized by the Russian Longevity Alliance. Another large conference took place in Moscow, on the “Quality of Life of Older Persons”, supported by the Gerontological Society of the Russian Academy of Sciences, focusing on geroprotective substances and therapies.

4. In Gomel, Byelorussia, at the end of September, a conference took place on the general subject of Radiobiolgy, at the Institute of Radiobiology of the National Academy of Sciences of Byelorussia, with a leading section on the biology of aging and longevity (“gerontological aspects of man-made factors”).

5. Another  small conference took place in New Delhi, India, organized by Future Tech and the Solutions For the Future, with the help of India Future Society, and other groups. Toward that day, India Future Society also started a crowdfunding campaign to develop a website dedicated to advancement of emerging and life-extending technologies.

6. A series of promotions was organized in Pakistan, by the Pakistan National Academy of Young Scientists and the University of Lahore. The newly formed Pakistan Aging Research Society (PARS) organized an entire month long campaign, “Go for Life” – from September 1 until October 1 – to encourage physical activity of older persons, as well as held a special promotion.

7. In Rome, Italy, a conference was organized by the Italian Transhumanist Association, the Italian Longevity Alliance and several other Italian progressivist and life-extensionist organizations ( http://www.meteoweb.eu/2015/10/scienza-roma-il-24-ottobre-si-terra-il-longevity-day-italia/524667/ ; http://www.longevityday.it/; photos)

8. In Manila, Philippines, a new advocacy group on emerging technological applications to medicine, in particular aging research, was initiated in honor of that day.

9. Also in Potrugal, at the University of Porto a meeting was held by the Human Genetics Group .

10. Additional meetings and promotions were done by the European Healthy Life Extension Society (HEALES) in Brussels, Belgium, including a Competition for the Best Short Film on Life Extension. The winners: First Prize, Second First Prize ; Third Prize.

11. In Germany, meetings were held by two new officially registered political parties that emphasize the development of biomedical research in their programs: in Berlin, by the German Health Research Party and in Stuttgart by the German Transhumanist Party. At the end of September, there also took place in Germany the (unrelated) conference on the Treatment of Elderly Patients: The Challenge of the Future, in Halle, accompanied by workshops on Bioinformatics in Ageing Research. And out of Bremen, Germany, a promotional video on longevity research (the bioengineering approach) was created as a part of the campaign, on behalf of Science Communicator, by Hashem Al-Ghaili, which reached over 1 million views on Imgur, Facebook, Youtube and Reddit.

12. An online promotion (videoconference) in Spanish was held by the Venezuela Longevity Alliance (together with longevity activists from across Latin America).

13. A similar videoconference (recorded) in Portuguese was organized for Brazil by the Brazil Longevity Alliance. A special publication and a radio interview in honor of that day were issued. A conference took place at the HCor- Hospital do Coração, in the state of Sao Paulo, Brazil, which held a dialogue with health professions and aging experts. The event program was created to emphasize the importance of aging and longevity research for the development of effective health care for the elderly. The event theme: “The ageing populations and the impact on health services”. And yet another online conference on longevity science and esthetics was organized from Piúma, Brazil.

14. An on-line promotion of the day was done in Colombia by Vida Prolongada (http://vidaprolongada.com/), promoting the position paper on the “critical need to promote research of aging” in Spanish.

15. An online event was held in Spain by the new association Movimiento Transhumanista founded by Alianza Futurista‘s working group. A special promotion and endorsement of The Longevity Day initiative and the position paper on the “Crticial Need to Promote Research of Aging” were done by the AECES – Asociación Española para el Estudio Científico del Envejecimiento Saludable, Spanish Association for the Scientific Study of Healthy Ageing. (http://www.longevidad.org/)

16. A meeting and a pro-longevity documentary promotion were done in Helsinki by Longevity Finland – Pitkäikäinen Suomi. 

17. In Slovakia, longevity activists distributed flyers advocating for public promotion of longevity research.

18. A meeting was held in Stockholm, Sweden, by Aldrandefonden/Svenska Livsförlängningssällskapet SLFS – Swedish Life Extension Society http://www.aldrandefonden.se/.

19. In the UK, the London Futurist community celebrated longevity research as a part of a discussion of emerging technologies in London.

20. In Larnaca, Cyprus, the ELPIS Foundation, together with the local gerontological community, held a seminar “Health in Older Life” in honor of that day.

21. In Perth, Australia, a meeting was held by the “Healthy Longevity Philosophy” society. Another promotion was done by Science, Technology and the Future society in Melbourne, Australia, including interviews with prominent longevity researchers and advocates such as Dr. Aubrey De Grey, Chief Science Officer of SENS Research Foundation. 

22. In Kiev, Ukraine, a seminar is organized by longevity activists on behalf of the Kiev Institute of Gerontology of the Ukrainian Academy of Medical Sciences.

23. In Beijing, China, a meeting was organized by the Technium community.

24. In Uganda, the Kasese Freethinkers Sports Academy educated about the connection between physical activity and longevity and the benefits and causes of healthy longevity.

25. A mini-seminar is being organized in Lagos, Nigeria, by Longevity Nigeria group, as well as an on-line promotion of longevity.

26. In Romania, a conference is being held at Äna Aslan National Institute of Gerontology and Geriatrics, in Bucharest, toward the end of October (as a part of the “Longevity Month”). This was preceded by online promotions and meetings of Romanian longevity activists.

27. In Vietnam, Hanoi, the Vietnam Public Health Association held a conference on the Mental Health of the Elderly, emphasizing biomedical research on neurodegenerative diseases.

28. In Singapore, a seminar on biology of aging was organized at CREATE – Campus for Research Excellence and Technological Enterprise. This precede a large Biology of Aging Conference organized by the Singapore Immunology Network (A*Star) – not “officially” a part of the “Longevity Day” events, but perhaps of the “Longevity Month.”

29. At about the same time, the 10th Asia / Oceania Congress of Gerontology and Geriatrics 2015 for “Healthy Aging Beyond Frontiers” will take place in Chiangmai, Thailand, including sections on biology of aging.

30. In Paris, France, a seminar was organized at the Biopark Cancer Campus, University Paris Sud. Another meeting took place in Paris at Centre de Recherches Interdisciplinaires (CRI – Center for Interdisciplinary Research) on behalf of Longévité & Santé . And yet another event was conducted in Paris in association with the “Longevity Day” – the screening of the film “Immortalists”.

31. In South Korea, the Korean Branch of Solutions for the Future organized a meetup in Seoul.

32. In Switzerland, Zurich, the Swiss Longevity Alliance organized a mini-conference on longevity research. This will shortly follow a large international symposium on geroprotectors in Basel.

33. In Poland, the Warsaw University Students Association supported the organization of a discussion on life extension science. This followed an (unrelated) conference on Healthy Aging in Warsaw. Also, on October 1, a new site was initiated by longevity activists from Krakow http://agingandlongevity.pl/en/aging-and-longevity/

34. In Canada, at Huntington University, an event was held by the Canadian Institute for Studies in Aging (CISA). In Alberta University, Canada, a special discussion on Technology and the Future of Medicine was dedicated to that day. And yet another meetup was held in Vancouver on behalf of the Lifespan Society of British Columbia.

35. In Iran, a study group was conducted in Tehran on behalf of the Iran Longevity Alliance  http://www.iranlongevity.com/.

36. Yet another study group was held in Cairo, Egypt, by the Egyptian Longevity Alliance http://www.egyptplus.org/.

37. And yet another free discussion of longevity science will take place in Tirana, Albania – the first longevity research activism event in the country. 

38. An on line promotion was done by South African longevity activists. They have also promoted the Longevity Day campaign through the People’s Health Movement, emphasizing the urgent need to improve the longevity in South Africa and Africa generally.

39. A small meeting of longevity activists was held in Taipei, Taiwan. This preceded the (unrelated) “Aging Innovation Week” in Taipei.

40. In Bulgaria, events toward the International Longevity Day started earlier in September with a conference in Ravda, organized by the University for National and World Economy, Department of Management and BASAGA – Bulgarian Academic Simulation and Gaming Association, including a section on Futurism, Transhumanism and Longevity, and continuing up to the date itself with more live and online discussions and publications and a special appeal in honor of that day.

41. In Tokyo, Japan, Exponential Technologies Institute held a promotion of longevity science in the framework of Tokyo-Singularity-Meetup.

42. A meeting was held in the National Library in Tbilisi, Georgia, by activists of the Georgian Longevity Alliance, including presentations on the development of longevity science in Georgia and the world, and debates. In honor of that day, an article was published in one of Georgia’s most popular newspapers – Asaval Dasavali http://www.longevityforall.org/longevity-day-in-the-republic-of-georgia/

43. In Morocco, a new website dedicated to promotion of longevity research was initiated by the For Bladi Association http://www.longevity.ma/.

44. In Amsterdam, the Netherlands, an event was organized by the WAAG Do It Yourself Biology (DIY-BIO) Society.

Thanks to all the organizers and participants! Please add your support and more events and publications for this initiative now and in the future! If you would like to get involved, please let know!

You are also welcome to promote this initiative on social media:

https://www.facebook.com/events/1017229998296364/

https://www.facebook.com/LongevityDay

Preparations for the next year’s International Longevity Day – October 1 – already started as well. The next global conference of the International Society on Aging and Disease (ISOAD) will take place in Stanford on October 1-2, 2016. The topics will range from interventions for longevity through stem cell research, genetics and systems biology of aging, to public support for aging research. The submission of abstracts and proposals is already started and welcome. And a conference is being planned in Brussels, for September 29-October 1, 2016, by the European Healthy Life Extension Society – Heales.

Hopefully, thanks to these and many other events, in this year and in the years to come, the importance of biological aging and longevity research will gradually become a strong theme of the international healthcare agenda, for the elderly and for the entire population.

Ilia Stambler, PhD.

Outreach coordinator. International Society on Aging and Disease (ISOAD)

http://isoad.org/

ilia.stambler@gmail.com

Thank you!

A Necessidade Crítica de Promover a Pesquisa em Envelhecimento ao Redor do Mundo

logo-ISOAD

A Necessidade Crítica de Promover a Pesquisa em Envelhecimento ao Redor do Mundo

Abaixo está a carta de posição sobre A Necessidade Crítica de Promover a Pesquisa em

Envelhecimento da Sociedade Internacional sobre Envelhecimento e Doença (International

Society on Aging and Disease – ISOAD). Este documento detalha brevemente o raciocínio,

tecnologias e políticas que são necessárias para promover esta pesquisa. Portanto, ele pode

servir como uma defesa da aplicação geral ou de lobby em diferentes países. Por favor, ajude a

difundi-lo. Por favor, contribua para o maior reconhecimento possível e apoio à investigação

biológica sobre o envelhecimento e doenças relacionadas ao envelhecimento. Agradecemos

aos leitores por fazer circular esta carta de posição, compartilhá-la em suas redes sociais,

enviá-la para os políticos, potenciais benfeitores e os meios de comunicação, organizar grupos

de discussão para discutir as questões levantadas (que mais tarde podem se transformar em

grupos de pesquisa e ativismo da longevidade em diferentes países), traduzir esta carta de

posição para o seu idioma, dando referência e link a ela, inclusive republicá-la em parte ou

completa (por exemplo, recomendações políticas podem caber em um panfleto de uma

página), juntar-se a ISOAD ou outra organização sobre pesquisa e divulgação de

envelhecimento e longevidade.

Originalmente publicado na revista Aging and Disease, 6 (1), 2015, ISOAD.

http://www.longevityforall.org/the-critical-need-to-promote-research-of-aging-around-the-world/

http://www.aginganddisease.org/EN/10.14336/AD.2014.1210

A necessidade crítica de promover a investigação sobre o envelhecimento e doenças

associadas ao envelhecimento para melhorar a saúde e longevidade da população idosa

Resumo

Devido ao envelhecimento da população global e o derivado crescimento ligados a doenças

não-transmissíveis relacionadas com o envelhecimento e seu peso econômico, há uma

necessidade urgente de promover a investigação sobre o envelhecimento e doenças

relacionadas ao envelhecimento, como forma de criar uma longevidade saudável e produtiva

para a população idosa. Para atingir este objetivo, promovemos as seguintes políticas: 1)

Aumentar o financiamento para a pesquisa e desenvolvimento dirigido especificamente para

retardar os processos degenerativos do envelhecimento e prolongar a expectativa de vida

saudável e produtiva da população; 2) Fornecer um pacote de incentivos para as organizações

comerciais, acadêmicas, públicas e governamentais para incentivar tal compromisso em

pesquisa e desenvolvimento; e 3) estabelecer e expandir as estruturas de coordenação e

consulta, programas e instituições ligadas ao envelhecimento investigação, desenvolvimento e

educação na academia e indústria, agências de política pública para níveis

supragovernamentais e governamentais.

O desafio do envelhecimento da sociedade e potenciais soluções

Durante as últimas décadas, a esperança média de vida aumentou globalmente, chegando a

uma média global de cerca de 70 anos em 2014 (seis anos mais do que em 1990) e cerca de 80

nos países desenvolvidos (em comparação com cerca de 50 em países desenvolvidos no início

do século XX). Esta evolução tem sido particularmente atingida através de melhorias nos

cuidados de saúde, os avanços da medicina, o aumento dos padrões de vida e declínio nos

índices de mortalidade infantil. Atualmente, enquanto as expectativas de vida mais longa

ainda estão nos países “desenvolvidos”, os maiores e mais rápidos aumentos foram

registrados nos países “em desenvolvimento”. Dada a demografia da população mundial entre

2000 e 2050 a proporção de pessoas com mais de 60 anos vai dobrar de cerca de 11% a 22%, o

que, em termos absolutos, um aumento de 605 milhões a 2 bilhões de pessoas [1-3].

Apesar do aumento da expectativa de vida geralmente refletir o desenvolvimento humano

positivo, novos desafios estão surgindo. Eles surgem do fato de que o envelhecimento ainda

está intrinsecamente associado com declínio biológico e cognitivo, embora a gravidade, a

velocidade de declínio cognitivo, a fragilidade física e deficiências psicológicas possam variar

entre os indivíduos.

Todavia, processos degenerativos de envelhecimento são as principais causas subjacentes de

doenças não-transmissíveis, incluindo câncer, isquemia cardíaca, acidente vascular cerebral,

diabetes tipo 2, Alzheimer etc. A deterioração da saúde mental devido a doenças

neurodegenerativas crônicas representam a principal causa de incapacidade em todo o

mundo, representando mais de 20% dos anos vividos com incapacidade. Portanto, maiores

esforços devem ser direcionados para a cura. De acordo com a Organização Mundial de Saúde

(OMS) no “Duodécimo Programa Geral de Trabalho” (13 de abril de 2013), uma das principais

prioridades da OMS é “Enfrentar o desafio das doenças não-transmissíveis” [4], e abordar o

envelhecimento se encaixa nesta definição e é inclusive necessário para atender a essa meta

prioritária.

Envelhecimento também aumenta o risco de morbidade e mortalidade por doenças

infecciosas, como pneumonia e influenza. Além disso, a suscetibilidade à lesão ou trauma

(como quedas e contusões), devido à deterioração do equilíbrio e estado mental, e até mesmo

sujeitos a violência, é fortemente aumentada pelo processo de envelhecimento. Ademais, o

processo de envelhecimento exacerba e fortalece os efeitos de outros fatores de risco para

doenças não-transmissíveis (uso de tabaco, dietas não saudáveis, inatividade física e consumo

excessivo de álcool). Em suma, a deterioração da saúde relacionada ao envelhecimento é uma

das principais causas de mortalidade e morbidade no mundo inteiro e deve ser tratada de

acordo com a gravidade do problema. Tendo em conta esses efeitos severos e negativos, o

envelhecimento é agora visto como um dos maiores desafios econômicos e sociais que a

maioria dos países – especialmente no mundo industrializado – irão enfrentar nas próximas

décadas.

Vários relatórios de governos nacionais, organizações internacionais como as Nações Unidas

(ONU) e OMS, bem como as companhias de seguros, organizações de bem-estar e

organizações não-governamentais (ONGs), têm se referido aos desafios socioeconômicos e de

saúde das sociedades em envelhecimento. Esses incluem:

> Aumento dos custos dos planos de saúde e estresse financeiro para os sistemas de segurança

social devido ao aumento do risco de doenças relacionadas à idade.

> A demência é muitas vezes mencionada como particularmente problemático já que exige

mais cuidados intensivos, que impõem um pesado fardo sobre os familiares que trabalham ou

exigem custos adicionais significativos para a provisão de cuidados profissionais.

> Uma força de trabalho em declínio já está ocorrendo, especialmente nos países

industrializados. Embora as pessoas queiram ficar ativas no trabalho por mais tempo, elas

podem ser incapazes, devido ao comprometimento cognitivo e físico.

> Um número crescente de pensionistas precisa ser financiado, enquanto um número maior de

trabalhadores precisa prestar cuidados médicos que devem manter preços acessíveis.

> Existem preocupações substanciais sobre a condição de qualidade de vida e idoso devido a

doenças relacionadas à idade, à degeneração biológica e ao aumento do risco de sucumbir a

condições de doenças graves e com risco de vida.

> Um declínio geral na qualidade de vida priva muitos idosos em qualquer atividade social,

cultural ou intelectual.

O desafio da sociedade em envelhecimento tem sido amplamente reconhecido e vários

programas de pesquisa e desenvolvimento ao redor do mundo começaram a abordar as

doenças relacionadas ao envelhecimento, tais como a Campanha para prevenir a doença de

Alzheimer e o Programa de Prevenção a Diabetes da OMS, bem como o desenvolvimento de

tecnologias, como robôs cuidadores, detectores de queda e tecnologias para Ambientes de

Vida Assistida, ou tornar as acomodações e infraestruturas mais amigáveis e acessíveis para

casas mais antigas. Embora tais investimentos sejam louváveis ​​e compreensíveis, dada a

urgência do problema, todos eles representam soluções pontuais.

Em particular, as tecnologias de apoio, as mudanças de infraestrutura ou melhoria das

instalações de enfermagem não resolvem o problema central da degeneração biológica

associada ao envelhecimento. Os esforços da investigação médica e desenvolvimento está

atualmente focada em doenças específicas, tais como a doença de Alzheimer, doença cardíaca,

osteoporose, diabetes, câncer, etc. Os processos degenerativos subjacentes do

envelhecimento, determinantes para o surgimento dessas doenças , são muitas vezes

subestimados, não ganhando ênfase.

Enquanto o processo de envelhecimento degenerativo, que envolve a acumulação de danos

estruturais, o equilíbrio metabólico prejudicado e o seu funcionamento é um processo

debilitante que exige prevenção e tratamento. Alcançar a longevidade saudável, caracterizada

pela manutenção da capacidade funcional e robustez, é a sua cura.

Alguns dos efeitos do processo de envelhecimento degenerativo podem ser modificados por

fatores sociais e econômicos, bem como estilo de vida (dieta, exercícios etc.), mas apenas de

forma modesta. Em seguida, há uma necessidade de promover uma pesquisa na área da

biologia do envelhecimento e doenças relacionadas à idade como o caminho para melhorar

mais substancialmente a saúde dos idosos.

Novos rumos em pesquisas e desenvolvimento tomam uma abordagem mais holística para

combater os processos degenerativos e os efeitos biológicos negativos do envelhecimento

humano, abordando diversas causas fundamentais do envelhecimento e doenças relacionadas

à idade, concomitantemente e de forma interligada. Por exemplo, no Congresso Geroscience

das Instituições Nacionais de Saúde dos Estados Unidos, de 2013, as seguintes áreas de

pesquisas prioritárias foram identificadas: Adaptação ao Estresse, Epigenética, Inflamação,

Danos Macromoleculares, Metabolismo, Proteostase e Células-tronco/Regeneração [10,11],

mas há muitos outros exemplos de abordagens semelhantes, priorizando a pesquisa de

grandes conjuntos de processos de envelhecimento [12-17]. Em vez de apontar doenças

relacionadas à idade em particular, os próprios mecanismos de envelhecimento estão sendo

analisados, a fim de que se encontre formas de intervenção e prevenção. Estas abordagens são

muito promissoras pelas seguintes razões:

> Elas já são suportadas por provas científicas de conceito, envolvendo o evidente aumento

saudável da expectativa de vida de modelos animais e as capacidades tecnológicas emergentes

para intervir no processo fundamental de envelhecimento [12,18-23].

> Elas podem fornecer soluções para uma série de doenças não-transmissíveis relacionadas ao

envelhecimento, na medida em que essas doenças são fortemente determinadas por

processos degenerativos do envelhecimento (como inflamação crônica, reticulação de

macromoléculas, mutações somáticas, perda de populações de células-tronco e outros) [24-

28]. Além disso, é provável que reduza a suscetibilidade dos idosos às doenças transmissíveis

devido a melhorias na imunidade [29].

> Os inovadores e aplicados resultados da pesquisa e desenvolvimento levarão a soluções

sustentáveis para uma grande variedade de desafios médicos e sociais relacionados com a

idade.

> Tal pesquisa e desenvolvimento devem ser apoiados em bases éticas, para proporcionar

igualdade de acesso aos cuidados de saúde para os idosos e os jovens.

Portanto, é dever da sociedade, especialmente dos profissionais em Biologia, Medicina,

Biomedicina, Cuidados de Saúde, Economia e organizações sociopolíticas, recomendar

fortemente o aumento do investimento em pesquisas e desenvolvimentos dedicados à

compreensão dos mecanismos associados ao processo biológico de envelhecimento humano e

transformar essas descobertas em tecnologias e tratamentos seguros, acessíveis e

universalmente disponíveis.

Assim sendo, podem haver grandes benefícios para a sociedade, a economia e a qualidade de

vida em geral para priorizar e acelerar a pesquisa, desenvolvimento e inovação nesta área,

incluindo o seguinte:

– A medicina regenerativa – incluindo o desenvolvimento de células-tronco e seus produtos,

regeneração de órgãos e tecidos in vivo e ex vivo, a morte celular controlada, imunossupressão

de células senescentes ou células cancerosas.

– Engenharia de Tecidos – Cultivo e fusão de uma ampla variedade de órgãos e tecidos de

reposição, vasculares e não-vasculares, utilizando métodos como a impressão 3D, “andaimes”

(polímeros) biodegradáveis, biorreatores ou auto-organização.

– Regulação da homeostasia de todo o corpo, incluindo a regulação do ritmo circadiano, e

biorreguladores neuro-humorais moleculares.

– Substâncias Gerontoprotetoras – Por exemplo, antiglicêmico, estatinas, anticoagulantes,

antioxidantes, moduladores de hormônios, moduladores da mitocôndria, anti-inflamatórios,

probióticos e biomedicamentos.

– Desintoxicação no nível celular e molecular – por exemplo, agentes quelantes, adsorção

enteral, digestores de produtos de glicação avançada (AGE-breakers), despolimerização redox,

imunidade ativa, liberação enzimática etc.

– Suplementação Dietetica – Estabelecimento de requisitos nutricionais na dieta dos idosos e

durante todo o curso da vida, por exemplo, o uso de suplementação com vitaminas,

microelementos, compostos macroérgicos.

– Terapia Gênica – A engenharia genética e estimulação farmacológica segura de “genes da

longevidade” (por exemplo Sirtuins e FOXO), atenuação dos “Fatores Aceleradores de

Deterioração” (DAF), manipulação de caminhos genéticos que promovem a longevidade (por

exemplo, via mTOR), estimulação da atividade da telomerase, a interferência do RNA,

sequenciamento e mapeamento genético e epigenético.

– Nanomedicina – Por exemplo, nanopartículas para administração farmacêutica, protótipos

emergentes de imunidade artificial, micro e nano-dispositivos fornecedores de oxigênio e

dispositivos para a reparação de tecidos macromoleculares.

– Substituição com órgãos artificiais e estímulo eletrofisiológico – por exemplo, próteses

funcionais e órgãos, neuropróteses, interfaces “cérebro-computador” avançadas, estimulação

eletrofisiológica de funções neurológicas e musculares danificadas.

– Autoquantificação – abrangente automonitoramento e diagnósticos personalizados das

condições vitais e daquelas relacionadas ao envelhecimento, regimes calculados para uma

alimentação saudável e equilibrada e atividade física suficiente para os idosos.

– Mineração de Dados – grandes dados analíticos sobre a saúde, descobrimento de

intervenções candidatas eficazes, modelos do processo de envelhecimento, doenças e

intervenções antienvelhecimento que sejam formais e quantitativos e, ainda, que sejam

também visualmente acessíveis e interativos.

– Criopreservação e Quimiopreservação – benéfica para o transplante de órgãos ou tecidos e

para um conhecimento mais profundo sobre a fisiologia do envelhecimento.

Apontar processos debilitantes associados com o envelhecimento através de meios

biomédicos deve tornar-se uma abordagem inovadora e poderosa e um padrão médico para a

prevenção de doenças não-transmissíveis que afetam principalmente pessoas em estágios

avançados da vida. O objetivo da medicina preventiva para os idosos, utilizando tecnologias

biomédicas avançadas, é preservar a saúde de uma pessoa em envelhecimento para evitar

comprometimento funcional.

Os governos devem assegurar a criação e implementação das seguintes políticas para

promover a pesquisa sobre a biologia do envelhecimento e sobre doenças relacionadas ao

mesmo, a fim de melhorar a saúde da população idosa global:

1) Financiamento:

Garantir um aumento significativo do financiamento governamental e não-governamental

para pesquisas dirigidas por metas (translacional) na prevenção dos processos degenerativos

do envelhecimento, deficiências e doenças crônicas não-transmissíveis para prolongar a vida

saudável e produtiva, durante todo o curso da vida.

Especificamente:

– Dedicar uma parte designada do orçamento dos ministérios relevantes, tais como os

ministérios da saúde e/ou da ciência, particularmente nas divisões relativas à pesquisa

e tratamento de doenças crônicas não-transmissíveis.

– Dedicar uma porcentagem específica do rendimento dos lucros comerciais de

empresas farmacêuticas, biotecnológicas e de tecnologias médicas para essa pesquisa

e desenvolvimento.

– Estabelecer bolsas de pesquisa relevantes, com base em competência e dirigida para o

alvo.

– Dobrar o financiamento para esse tipo de pesquisa a cada 5 anos pelos próximos 20

anos.

2) Incentivos:

Desenvolver e adotar quadros jurídicos e regulamentares que forneçam incentivos para a

pesquisa e desenvolvimento. Criados, especificamente, para indicar o desenvolvimento,

registro, administração e acessibilidade de medicamentos, tecnologias médicas e outras

terapias que retardam o processo de envelhecimento e suas doenças correlacionadas e,

finalmente, prolongar a vida.

Especificamente:

– Desenvolver critérios relativos à eficácia e segurança de terapias gerontoprotetivas.

– Facilitar experimentos in silico, em animais e experimentos éticos e, sobretudo,

seguros, em humanos.

– Implantar e garantir terapias gerontoprotetivas na condição de terapias adjuvantes

com potencial para prolongar a vida.

– Proporcionar um percurso de aprovação encurtado para terapias com alto nível de

evidência de eficácia em ensaios clínicos e pré-clínicos, bem como em casos de

degeneração avançada e condições aparentemente fúteis.

– Garantir especial reconhecimento, reputação e benefícios a entidades comerciais e

públicos envolvidos em tal pesquisa e desenvolvimento.

3) Instituições:

Estabelecer e expandir a coordenação e estruturas de consultoria nacionais e internacionais,

programas e instituições destinados a promover a pesquisa, o desenvolvimento, a educação

sobre a biologia do envelhecimento e doenças relacionadas e o desenvolvimento de diretrizes

clínicas para modular os processos de envelhecimento e assim estender o tempo de vida

saudável e produtivo para a população.

Especificamente:

– Criar a especialização de Biogerontólogo, além de cursos em Biogerontologia como

parte um currículo comum nas universidades.

– Desenvolver e disseminar regimes gerontoprotetivos, com base nas melhores

evidências disponíveis, como parte das recomendações de saúde autorizadas.

– Estabelecer centros cooperativos de excelência para estudos fundamentais,

translacionais e aplicados, além de centros de análise estratégica, previsão, educação e

desenvolvimento de políticas sobre envelhecimento e pesquisa em longevidade. Tanto

em instituições acadêmicas como em várias agências governamentais e

supragovernamentais.

Estas medidas destinam-se a reduzir a carga dos processos de envelhecimento sobre a

economia e aliviar o sofrimento dos idosos e a dor emocional de seus entes queridos. Do lado

positivo, se for recebido apoio suficiente, essas medidas podem aumentar a expectativa de

uma vida saudável em idosos, que prorroga o período de produtividade e sua interação com a

sociedade, e aumenta a sua sensação de prazer, propósito igualdade e valorização da vida [30].

Sociedade Internacional Sobre Envelhecimento e Doença (ISOAD)

Comitê Executivo:

Prof. Kunlin Jin. Department of Pharmacology and Neuroscience, University of North Texas, Health Science

Center. Fort Worth, Texas, USA. ISOAD Chair

Email: kunlin.jin@unthsc.edu

Prof. James W. Simpkins. Center for Basic and Translational Stroke Research, West Virginia University.

Morgantown, West Virginia, USA. ISOAD President

Email: jwsimpkins@hsc.wvu.edu

Prof. Xunming Ji. Department of Neurosurgery, Xuanwu Hospital, Capital Medical University. Beijing, China.

ISOAD Vice Chair

Email: jixunming@vip.163.com

Dr. Miriam Leis. Fraunhofer Society for the Advancement of Applied Research. Munich, Germany. ISOAD Policy

Advisor

Email: miriam.leis@zv.fraunhofer.de

Dr. Ilia Stambler. Department of Science, Technology and Society, Bar Ilan University. Ramat Gan, Israel. ISOAD

Outreach Coordinator

Email: ilia.stambler@gmail.com

Tradução: Fabiane Pohlmann de Athayde

Referências:

[1] World Health Organization (2014). World Health Statistics – Large Gains in Life Expectancy. Accessed

December 2014. Retrieved from: http://www.who.int/mediacentre/news/releases/2014/world-health-statistics-

2014/en/.

[2] Human Mortality Database. Accessed December 2014. Retrieved from: http://www.mortality.org.

[3] United Nations, Department of Economic and Social Affairs, Population Division (2011). World Population

Prospects: The 2010 Revision, CD-ROM Edition. Accessed December 2014. Retrieved from:

http://esa.un.org/wpp/.

[4] World Health Organization (2013). Draft Twelfth General Programme of Work. Accessed December 2014.

Retrieved from: http://www.who.int/about/who_reform/programme_priority/en/.

[5] World Health Organization (2014). Ageing and Life Course. Accessed December 2014. Retrieved

from:http://www.who.int/ageing/en/.

[6] United Nations, Department of Economic and Social Affairs, Population Division (2013). World Population

Aging Report. Accessed December 2014. Retrieved from: http://www.un.org/en/development/desa/population/.

[7] The International Longevity Center Global Alliance (2010). Global Aging Report. Threats to Longevity. A Call

to Action. Accessed December 2014. Retrieved from: http://www.ilc-alliance.org/index.php/reports/.

[8] Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. (2012). Global and regional mortality

from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of

Disease Study 2010. Lancet, 380:2095-2128.

[9] Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. (2012). A comparative risk

assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions,

1990–2010: a systematic analysis for the Global Burden of Disease Study 2010, Lancet, 380:2224-2260.

[10] Kennedy BK, Berger SL, Brunet A, Campisi J, Cuervo AM, Epel ES, et al. (2014). Geroscience: linking aging

to chronic disease. Cell, 59:709-713.

[11] Healthspan Campaign (2013). NIH Geroscience Interest Group (GSIG) Releases Recommendations from the

October 2013 Advances in Geroscience Summit. Accessed December 2014. Retrieved

from:http://healthspancampaign.org/2014/02/27/nih-geroscience-interest-group-gsig-releases-

recommendations-october-2013-advances-geroscience-summit/

[12] Fahy GM, West MD, Coles LS, Harris SB (Eds). The Future of Aging: Pathways to Human Life Extension.

New York: Springer; 2010.

[13] Fontana L, Kennedy BK, Longo VD, Seals D, Melov S (2014). Medical research: treat ageing. Nature,

511:405-407.

[14] López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G (2013). The hallmarks of aging. Cell, 153:1194-

1217.

[15] De Grey ADNJ, Rae M. Ending Aging. The Rejuvenation Breakthroughs That Could Reverse Human Aging in

Our Lifetime. New York: St. Martin’s Press; 2007.

[16] Goldman DP, Cutler D, Rowe JW, Michaud PC, Sullivan J, Peneva D, Olshansky SJ (2013). Substantial

health and economic returns from delayed aging may warrant a new focus for medical research. Health Aff,

10:1698-1705.

[17] Rae MJ, Butler RN, Campisi J, de Grey ADNJ, Finch CE, Gough M, et al. (2010). The demographic and

biomedical case for late-life interventions in aging. Sci Transl Med, 2:40cm21.

[18] Kanfi Y, Naiman S, Amir G, Peshti V, Zinman G, Nahum L, et al. (2012). The sirtuin SIRT6 regulates lifespan

in male mice. Nature, 483:218-221.

[19] Atala A. Extending life using tissue and organ replacement (2008). Curr Aging Sci, 1:73-83.

[20] Baati T, Bourasset F, Gharbi N, Njim L, Abderrabba M, Kerkeni A, et al. (2012). The prolongation of the

lifespan of rats by repeated oral administration of [60] fullerene. Biomaterials, 33:4936-4946.

[21] Kheir JN, Scharp LA, Borden MA, Swanson EJ, Loxley A, Reese JH, et al. (2012). Oxygen gas-filled

microparticles provide intravenous oxygen delivery. Sci Transl Med, 4:140ra88.

[22] Shawn M. Douglas SM, Bachelet I, Church GM (2012). A logic-gated nanorobot for targeted transport of

molecular payloads. Science, 335:831-834.

[23] Kennedy BK, Pennypacker JK (2014). Drugs that modulate aging: the promising yet difficult path ahead.

Transl Res, 163:456-465.

[24] Chung HY, Cesari M, Anton S, Marzetti E, Giovannini S, Seo AY, et al. (2009). Molecular inflammation:

Underpinnings of aging and age-related diseases. Ageing Res Rev, 8:18-30.

[25] Lunn JS, Sakowski SA, Hur J, Feldman EL (2011). Stem cell technology for neurodegenerative diseases. Ann

Neurol, 70:353-361.

[26] Baylis D, Bartlett DB, Patel HP, Roberts HC (2014). Understanding how we age: insights into inflammaging.

Longev Healthspan, 3:6.

[27] Dai DF, Chiao YA, Marcinek DJ, Szeto HH, Rabinovitch PS (2014). Mitochondrial oxidative stress in aging

and healthspan. Longev Healthspan, 3:6.

[28] Zieman S, Kass D (2004). Advanced glycation end product cross-linking: Pathophysiologic role and

therapeutic target in cardiovascular disease. Congest Heart Fail, 10:144-149.

[29] Bredenkamp N, Nowell CS, Blackburn CC (2014). Regeneration of the aged thymus by a single

transcription factor. Development, 141:1627-1637.

[30] This position paper of the International Society on Aging and Disease (ISOAD) was published on behalf of

the ISOAD Executive Committee as: Kunlin Jin, James W. Simpkins, Xunming Ji, Miriam Leis, Ilia Stambler

(2015). The critical need to promote research of aging and aging-related diseases to improve health and longevity

of the elderly population. Aging Disease, 6(1):1-5

http://www.aginganddisease.org/EN/10.14336/AD.2014.1210

ILA BRAZIL MANIFESTO

Nós defendemos o avanço de uma longevidade saudável para toda a população através da investigação científica, saúde pública, defesa e ativismo social. Enfatizamos e promovemos a luta contra o principal inimigo de uma longevidade saudável – o processo de envelhecimento.

O processo de envelhecimento é a raiz da maioria das doenças crônicas que afligem a população mundial. Esse processo é responsável pela maior parte da incapacitação e mortalidade, e precisa ser tratado apropriadamente. A sociedade precisa dedicar esforços para o seu tratamento e correção, assim como para qualquer outra doença material.

O problema do envelhecimento é grave e ameaçador. No entanto, muitas vezes testemunhamos a um esquecimento quase completo da sua realidade e gravidade. Há uma sútil tendência em ignorar-se o futuro, para distrair a mente do envelhecimento e da morte por envelhecimento, e até mesmo apresentar o envelhecimento e a morte sob uma luz enganosa, apologética e utópica. Ao mesmo tempo, há uma crença infundada de que o envelhecimento é um processo completamente incontrolável e inexorável. Essa desconsideração do problema e sensação infundada de impotência não contribuem para a melhoria do bem-estar dos idosos e de uma longevidade saudável. Há uma necessidade de apresentar-se o problema em sua gravidade e importância e atuar para a sua solução ou mitigação para o melhor do nosso potencial.

Nós convidamos a todos a elevar a consciência pública sobre o problema do envelhecimento em toda sua abrangência. Nós convidamos o público a reconhecer esse problema grave e dedicar esforços e recursos – inclusive econômicos, sócio-políticos, científicos, tecnológicos e midiáticos – a sua redução máxima possível ao benefício do processo de envelhecimento da população, por uma longevidade saudável. Nós promovemos a ideia de que a maturação mental e espiritual e o aumento de uma longevidade saudável não são sinônimos de envelhecimento e deterioração.

Defendemos o reforço e aceleração da pesquisa biomédica básica aplicada, bem como o desenvolvimento da inovação tecnológica, industrial, ambiental, de saúde pública e medidas educativas, especificamente direcionados a uma longevidade saudável. Se suficiente apoio for dado, essas medidas podem aumentar a expectativa de uma vida saudável da população idosa, o seu período de produtividade, a sua contribuição para o desenvolvimento da sociedade e da economia, bem como o seu senso de propósito, prazer e valorização da vida.

Defendemos que seja dado ao desenvolvimento de medidas científicas e ao prolongamento da vida saudável a maior quantidade de apoio público e político possível, não apenas através da comunidade profissional, mas também através do grande público.

Longevity Iran website

Longevity Iran Logo 2

We are very proud and delighted to announce the creation of the world’s first site in Persian dedicated to promotion of aging and longevity science! Longevity Iran:

http://www.iranlongevity.com/

It is a premier knowledge hub, including blog articles, books, databases, organizations and more. It will serve as an invaluable platform to promote longevity research and advocacy in Persian, and strengthen the Persian-speaking pro-longevity community in Iran and around the world!

Great many thanks to the site creators! And many thanks to all who supported this initiative. In fact, this was the project performed by the Iranian Longevity Alliance (https://www.facebook.com/groups/longevity.iran/), in cooperation with Israeli Longevity Alliance, and India Future Society! Let us hope there will be many more such international collaborations for the promotion of longevity for all! And let us hope there will be many more sites and materials on longevity science in all languages.

Please help this initiative to develop, by inviting Persian-speaking friends to contribute relevant materials or promoting the site in relevant venues.

Please create similar sites and materials on longevity science in your language!

Thank you!

Rise of Emerging Technologies – Arabic

egyptp10

كتاب صوتي حول ما بعد الانسانية و مصر+

Originally published

http://www.egyptplus.org/t365-topic#366


للتحميل كملفات منفصلة في صيغة mp3: اضغط هنا

Google drrive


لتحميل الكتاب الصوتي كامل في صيغة rar: اضغط هنا

Rar

و للاستماع اونلاين: اضغط هنا

http://egyptplus.podomatic.com/


Join Facebook Group: https://www.facebook.com/groups/LongevityEgypt


الكتاب الاكتروني للقراءة اونلاين و التحميل من نفس وصلة الmp3


مقدمة


نحن في ايجيبت بلص مهتمين بنشر علوم و تكنولوجيا ما بعد الانسانية, نحن نهدف الي زيادة الوعي و الاستعداد للمستقبل و الطفرة التكنولوجيا الوشيكة. و لكن ما هي “ما بعد الانسانية”؟


انها ببساطة فلسفة مستقبلية تقوم علي ان الخطوة التالية لتطور الانسان, هي الاندماج مع الآلة, التحام الجسد الحيوي بجسد آخر آلي, ذلك سوف يتم عن طريق تحميل وعي الشخص علي جهاز كمبيوتر او انسان آلي.


علماء المستقبل يتنبؤن ان هذه الخطوة آتية لا محالة, و مع استمرار تطور الذكاء الصناعي, نحن نري ان هذه الفلسفة منطقية و تستحق الاهتمام.


الشخص الذي يعتنق هذه الفلسفة يسمي “ما بعد انساني” و هو شخص عادي مع فرق انه يعتقد انه باستخدام فلسفة ما بعد الانسانية سوف يستطيع ان يسمو علي حدوده البيولوجية و يحلق عاليا كنوع بشري جديد.


في طريقه لتحقيق هذا الهدف يستخدم ادوات معينة, سوف يتم شرحها في سياق هذا الكورس.

الخلود البيولوجي


لو اردت ان تتأكد إذا كنت واحد مننا اسأل نفسك هذا السؤال: “لو في امكانك ان تعيش الي الابد في جسد صحي لا يشيخ, هل تود ذلك؟” الاجابة علي هذا السؤال هو ما يفرق بين الموتي الاحياء و ما بعد الانسانيون. الموتي الاحياء هم الاغلبية الساحقة في العالم, انهم هؤلاء الذين يقبلون الموت كأمر طبيعي و محبوب و لا يفكرون ابداً في البقاء علي قيد الحياة الي اجل غير محدد.


علي اية حال, لو جاوبت علي هذا السؤال بالقبول, فانت واحد من القلة القليلة التي تري العالم علي حقيقته و سوف تجد مكان لك في ايجيبت بلص, بين هؤلاء الذين يشاركونك الفكر.


في الحقيقة, نحن اقرب الي تحقيق الخلود اكثر من اي زمن آخر. حلم الخلود رافق البشرية منذ البداية, و في هذا العصر, في هذه الحياة, قد نري هذا الحلم يتحقق, اخيراً.


المابعدانسانيون يتبعون استراتيجيات متعددة لضمان بقائهم علي قيد الحياة لاطول فترة ممكنة. علي رأسها, حربهم مع الشيخوخة, نحن لا نريد فقط ابطاء الشيخوخة نحن نريد تفاديها من الاساس.


البقاء في جسد صحي و سليم الي مدد غير محددة, وجه من اوجه الخلود الذي يسعي اليه ما بعد الانسانيون.


في سبيل تحقيق ذلك نعمل علي دعم المنظمات الاخري التي تقوم بالفعل علي دراسة علوم الشيخوخة و اكتشاف علاج نهائي لها.

استعمار الفضاء


المعارضين لفكرة اطالة اعمار البشر يتحججون بأنه لن يكون هناك مكان علي الارض لاستيعاب اعداد اكبر من البشر, و يتناسون انه مع الطفرة التكنولوجيا لن يتحسن فرص بقاء الانسان لمدد اطول من المعتاد, سوف يتطور معها اساليب و طرق السفر عبر الفضاء.

حتي اثناء هذه اللحظة يتم اكتشاف كواكب جديدة مؤهلة للحياة البشرية, ليس ذلك فقط, بل يمكننا ان نخمن انه الآن يوجد قواعد بشرية علي القمر نفسه, و قريبا علي المريخ.

الارض هي كوكبنا الام, و لكن كما يقول العلماء ايضا, ان الارض هي بداية البشرية و لكنها ليست نهايتها.

علي اية حال, مع تطور التكنولوجيا لا يمكن التكهن بما هو ممكن فعلا في المستقبل, و لكن الاستمرار في هذا الاتجاه سوف يؤدي بالتأكيد الي تحقيق حلم السفر عبر الكواكب, من يدري, ربما تملك في المستقبل سفينتك الفضائية الخاصة!


العقل السليم في الجسم السليم


فلسفة الما بعد انسانية ليس في الواقع جديدة كلياً, لأن افكارها الاساسية بدأت مع بدأ الانسان علي كوكب الارض, لعل اقدم مثل علي ذلك هو ملحمة جلجامش, الملك الذي سعي للخلود, و من جلجامش الي العصور الوسطي و رحلة البحث عن اكسير الحياة, حتي علماء المسلمون انفسهم وضعوا اسس العلوم الحديثة لتحقيق هذا الغرض.

انه قدر الانسان ان يعيش الي الابد ابعد من النجوم.

من وجهة نظرنا, تعتبر الصحة الجيدة ركن اساسي من اسلوب الحياة الابدية, حيث منطقيا, ليس للخلود فائدة لو كنت تعيش في جسد متهالك.

ايجيبت بلص معناها مشتق من ما بعد الانسانية, حيث ان رمز هذه الفلسفة هو علامة الزائد التي تعني زيادة في تطور الانسانية. الدين المصري القديم كان يعلم ذلك و ذلك نشأ علم التحنيط.

الكريونكس هو علم حفظ الجسد البشري في درجة حرارة باردة, و هو المرادف المعاصر للتحنيط, مع اختلاف الاغراض بالطبع.

يمكن اعتبار ذلك الخطة “ب” و هو ما نشجع اعضائنا علي تحقيقه اثناء وجودهم في هذه الحياة, حيث انه لا ضمانة حقيقية, لذلك يجب عليك ان تفعل كل ما في قوتك لتحقيق خلودك. و ذلك ايجيبت بلص موجودة لتكون نقطة تركيز محلية علي تحقيق اهداف دولية.


الثقافة و الفن


في الاصل ما بعد الانسانية حركة علمية ثقافية شاملة. نحن نشجع اعضاءنا علي التعبير عن مواهبهم و اخراج الامكانية البشرية الي النور و تطويرها الي اقصي حدود ممكنة.

نحن نشجع اعضائنا علي تطوير انفسهم بكل الاساليب العلمية, نحن نريد ان يتم ابهارنا و توسيع ادراكنا باعمال اعضاءنا الفنية, لا يوجد حدود لما يمكنك تحقيقه لو ادركت ان حياتك علي هذه الارض تخدم غرض اساسي, هو محاربة الشيخوخة و الوصول الي المرحلة التالية من التطور.

نحن نؤمن انك بالفعل تملك المؤهلات اللازمة لتحقيق ذلك.


العصر القادم


يتنبأ العلماء انه بحلول سنة 2040 سوف يتم مقابلة جميع حاجات الانسان البشرية كالحاجة الي سكن و طعام الخ. و لكن متي تبدأ الطفرة التكنولوجيا؟ سوف تبدأ عند صناعة اول ذكاء صناعي متفوق علي الانسان. و لكن ماذا سوف يحدث عندما يستولي الذكاء الصناعي علي وظائفنا الحالية؟ ربما سوف يكون هناك وظائف اخري لا تحتاج الي ذكاء صناعي, ربما لن نحتاج الي وظائف لأنه لن يكون هناك حاجة الي النقود اصلا!

هذا ما توعدنا به التكنولوجيا, و لكن الآن دورنا هو ان نقوم بتحقيق هذا الوعد بأنفسنا. ربما نحن نعيش في محاكاة واقعية قام بصنعها بشر من المستقبل و هذا يعني اننا نجحنا في الوصول الي الطفرة, و الآن نريد ان نعمل علي تحقيقها “مرة اخري” حتي لا ينتهي جنسنا البشري من الوجود!

العصر القادم لن يكون للموتي الاحياء.

نانو تك


سيارات تقود نفسها, طباعة ثلاثية الابعاد في الفضاء, لحمة تنمو في المعمل, و حفظ جسم الانسان علي حالته الي اجل غير محدد, كل هذا و اكثر يحدث الآن ليس في المستقبل, ما كان يبدو لاجدادنا كخيال علمي اصبح واقع في العصر الذي نعيش فيه.

في المستقبل قد لا نحتاج الي العمل للحصول علي الطعام, ربما بمجرد ضغطة زر تحصل علي اي وجبة يمكنك تخيلها او لا تتخيلها الآن, ما ينتجه عشر مصانع في شهر, سوف يمكن لأي شخص عادي ان يقوم به بمجرد اشارة صغيرة بيده. و الاهم, علاج السرطان او الايدز قد يكون مجرد تطعيم في مرحلة الطفولة و هذا كل شيء.

عندما نتخلص تماما من الاهتمام الكلي بأبسط اساسيات البقاء, عندها سوف نكون اكثر حرية في السعي نحو اهداف اكبر و تحقيق امنيات اعظم, ان المستقبل يبدو اقرب من ذي قبل.

لذلك من الضروري التعاون علي تحريك العالم في اتجاه التطور العلمي و التكنولوجي و ان نترك الحروب و الصراعات و لو لوقت قصير حتي نحقق هدفنا في البقاء الي الابد.

تقنية النانو تجعل الانسان اكثر قدرة علي التحكم في المادة و تطويعها بشكل اكثر فعالية, بالتحكم في خصائص المادة علي مستوي دقيق جدا يمكن للانسان اخيرا تحويل المعادن الرخيصة الي ذهب, و ربما اكتشاف اكسير الحياة, و تطبيقها في مجال الطب يجعل الانسان قادر علي محاربة الشيخوخة و الامراض الاخري بطريقة نهائية, أخيرا نستطيع تسخير الطبيعة كما ينبغي.

المستقبل قد يحمل لنا اكثر من ما نتوقعه الآن, و لكننا لن نعلم ابداً إذا لم نفعل شيء!

La Imperiosa Necesidad de Promover la Investigación Sobre Envejecimiento

logo-ISOAD

Documento de Posición: La Imperiosa Necesidad de Promover la Investigación Sobre Envejecimiento

Original: http://ieet.org/index.php/IEET/more/stambler20150227

O http://www.longevityforall.org/the-critical-need-to-promote-research-of-aging-around-the-world/

A continuación está el documento de posición sobre La Imperiosa Necesidad de Promover la Investigación Sobre Envejecimiento de la Sociedad Internacional Sobre Envejecimiento y Enfermedades (International Society on Aging and Disease – ISOAD). Este documento brevemente detalla el razonamiento, las tecnologías y las políticas que son necesarias para promover esta investigación. Por lo tanto, puede servir como defensa de aplicación general o de cabildeo en diferentes países. Por Favor ayuda a difundirlo. Por Favor contribuye al más amplio posible reconocimiento y apoyo a la investigación biológica del envejecimiento y de enfermedades ligadas al envejecimiento. Agradecemos a los lectores que hagan circular este documento de posición, compartirlo en sus redes sociales, enviarlo a políticos, potenciales benefactores y medios de comunicación, organizar grupos de discusión para debatir los temas planteados (que luego sean semillas de investigación en longevidad y grupos activistas en diferentes países), traducir este documento de posición a su idioma, referir y enlazar a él, incluso publicarlo en parte o completo (por ejemplo, las recomendaciones políticas pueden caber en un volante de una página), unirse a la ISOAD u otra organización sobre investigación y divulgación de envejecimiento y longevidad.

Publicado originalmente en la revista Aging and Disease, 6 (1), 2015, ISOAD.
http://www.aginganddisease.org/EN/10.14336/AD.2014.1210


La Imperiosa Necesidad de Promover la Investigación del Envejecimiento y Enfermedades Ligadas al Envejecimiento para Mejorar la Salud y la Longevidad de la Población de Edad Avanzada

Resumen

Debido al envejecimiento de la población global y el derivado incremento en enfermedades ligadas a la edad intransmisibles, y su carga económica, hay una urgente necesidad de promover la investigación sobre envejecimiento y enfermedades ligadas a la edad como una manera de crear una longevidad saludable y productiva en la población de edad avanzada. Para conseguir este objetivo, promovemos las siguientes políticas: 1) Incrementar el financiamiento para la investigación y el desarrollo específicamente dirigido a aminorar los procesos de envejecimiento degenerativos y extender la expectativa de vida saludable y productiva de la población; 2) Proveer un conjunto de incentivos para las organizaciones gubernamentales, públicas, comerciales y académicas para fomentar el compromiso en dichas investigaciones y desarrollos; y 3) Establecer y expandir coordinaciones y estructuras de consultoría, programas e instituciones relacionadas a la investigación ligada al envejecimiento, desarrollo y educación en la academia e industria, agencias de políticas públicas a niveles gubernamentales y supra-gubernamentales.

El desafío de la sociedad envejecida y potenciales soluciones

Durante las décadas pasadas, la expectativa de vida promedio se ha incrementado globalmente, alcanzando un promedio global de cerca de 70 años en 2014 (6 años más que en 1990) y cerca de 80 en los países desarrollados (comparados con los cerca de 50 en países desarrollados a principios del siglo XX). Este desarrollo ha sido conseguido especialmente gracias a mejoras en la sanidad, avances médicos, aumento de los estándares de vida y un declinamiento en la mortalidad infantil. Actualmente, mientras que las expectativas de vida más largas se encuentran todavía en los países “desarrollados”, los incrementos más grandes y rápidos han sido registrados en los países “en desarrollo”. Considerando la demografía de la población mundial, entre el 2000 y el 2050 la proporción de personas sobre los 60 años se duplicará de cerca de un 11% a 22%, lo cual, en términos absolutos, significa un incremento de 605 millones a 2 billones de personas [1-3].

A pesar de que el incremento en la expectativa de vida en general refleja desarrollos humanos positivos, nuevos desafíos están apareciendo. Surgen del hecho de que envejecer está todavía inherentemente asociado con degeneración biológica y cognitiva, a pesar de la severidad y velocidad de la mengua cognitiva, la fragilidad física y la discapacidad psicológica pueden variar entre los individuos.

No obstante, los procesos de envejecimiento degenerativos son la mayor causa subyacente de las enfermedades intransmisibles (ENTs), incluyendo al cáncer, isquemia cardiaca, infarto, diabetes tipo 2, Alzheimer y otras. El deterioro de la salud mental debido a enfermedades neurodegenerativas crónicas, representan la mayor causa de discapacidad en el mundo, responsable por más del 20% de los años vividos con discapacidad. Por tanto, mayores esfuerzos deben ser dirigidos para su sanación. De acuerdo a la Organización Mundial de la Salud (OMS) en “Proyecto de Duodécimo Programa General de Trabajo” (Abril 13, 2013), uno de las principales prioridades de la OMS es “Abordar el desafío de las enfermedades intransmisibles” [4], abordar el envejecimiento encaja en esta definición y es incluso necesario para cumplir con este objetivo prioritario.

El envejecimiento además incrementa el riesgo de morbilidad y mortalidad por enfermedades infecciosas como la neumonía e influenza. Por otra parte, la susceptibilidad a heridas o trauma (como caídas y concusiones), debido al deterioro del balance y el estado mental, e incluso ser víctima de violencia, es fuertemente incrementada por el proceso de envejecimiento. También, el proceso de envejecimiento exacerba y refuerza los efectos de otros factores de riesgo de enfermedades intransmisibles (uso de tabaco, dietas poco saludables, inactividad física, e ingesta excesiva de alcohol). En suma, el deterioro de la salud derivado de la edad es la mayor causa de mortalidad y morbilidad mundialmente y debiera ser abordada de acuerdo a la severidad del problema. Dados estos severos efectos negativos, el envejecimiento es actualmente visto como uno de los desafíos económicos y sociales más grandes que la mayoría de los países -especialmente en el mundo industrializado- deberá enfrentar en las décadas venideras.

Varios reportes de gobiernos, organizaciones internacionales, como la Organización de Naciones Unidas (ONU) y la OMS, tanto como compañías de seguros, organizaciones de asistencia social y organizaciones no gubernamentales (ONGs), se han referido a los desafíos socioeconómicos y sanitarios de las sociedades en envejecimiento. Estos incluyen:

> Incremento de los costos de programas de salud y estrés financiero para los sistemas de seguro social debido al incremento en la probabilidad de sufrir enfermedades ligadas al envejecimiento.

> La demencia es a menudo mencionada como especialmente problemática ya que adicionalmente requiere cuidados intensivos, impone una pesada carga para familiares que trabajan o demanda costos adicionales significativos para cuidado profesional.

> Una fuerza de trabajo en declive ya se está observando, especialmente en países industrializados. A pesar de que la gente quiera participar en la fuerza de trabajo por más tiempo, puede que no sean capaces, debido al deterioro cognitivo y físico.

> Un creciente número de pensionados que necesitarán ser financiados, mientras que una gran cantidad de trabajadores necesitarán proveer cuidados médicos que deben conservar precios accesibles.

> Hay preocupaciones considerables sobre la calidad de vida y el estado de salud de los mayores debido a enfermedades ligadas a la edad, degeneración biológica e incremento en el riesgo de sucumbir ante condiciones severas y potencialmente mortales.

> Un declive general en la calidad de vida priva a muchos adultos mayores de cualquier actividad social, cultural o intelectual.

El envejecimiento es un desafío para sociedad que ha sido ampliamente reconocido y numerosas investigaciones y programas de desarrollo alrededor del mundo se han iniciado para enfrentar las enfermedades ligadas al envejecimiento, como la Campaña para Prevenir la Enfermedad de Alzheimer o el Programa de Prevención de Diabetes de la OMS, así como el desarrollo de tecnologías de cuidado como robots de asistencia, detectores de caídas y tecnologías para Ambientes de Vida Asistida, o hacer infraestructura y hogares más amigables y accesibles para los mayores. A pesar de que dichas inversiones son loables y entendibles, dada la urgencia del problema, todas ellas representan solo soluciones puntuales.

En particular, las tecnologías de asistencia, cambios de infraestructura o mejoramiento de instalaciones de enfermería, no resuelven el problema central de degeneración biológica asociado al proceso de envejecimiento. Los esfuerzos de investigación médica y desarrollo están actualmente enfocados en enfermedades particulares como el Alzheimer, enfermedades cardiacas, osteoporosis, diabetes, cáncer, etc. El proceso degenerativo subyacente, determinante para la emergencia de esas enfermedades, es a menudo pasado por alto.

Mientras que el proceso de envejecimiento degenerativo, que involucra la acumulación de daño estructural, el deterioro del equilibrio metabólico y su funcionamiento, es un proceso debilitante que requiere prevención y tratamiento. La consecución de longevidad saludable, caracterizada por la mantención de capacidades funcionales y robustez, es su cura.

Algunos efectos del proceso de envejecimiento degenerativo pueden ser modificados por factores económicos y sociales, así como por estilos de vida (dieta, ejercicio, etc), pero solo en una modesta extensión. Luego, hay una necesidad de promover la investigación en la biología del envejecimiento y enfermedades ligadas al envejecimiento como el camino para mejorar la salud de los mayores más sustancialmente.

Nuevas aristas en investigación y desarrollo toman una aproximación más holística para atacar el proceso degenerativo y los efectos biológicos negativos del envejecimiento humano, abordando varias causas fundamentales del envejecimiento y las enfermedades ligadas al envejecimiento al mismo tiempo y de una forma interrelacionada. Por ejemplo, en el Congreso Geroscience de las Instituciones Nacionales de la Salud de Estados Unidos de 2013, las siguientes áreas prioritarias de investigación han sido identificadas: Adaptación al Estrés, Epigenética, Inflamación, Daño Macromolecular, Metabolismo, Proteostasis, y Células Madre/Regeneración [10,11], pero hay muchos otros ejemplos de aproximaciones similares, priorizando la investigación de grandes conjuntos de procesos de envejecimiento [12-17]. En vez de apuntar a enfermedades ligadas al envejecimiento en particular, los mecanismos de envejecimiento en sí mismos están siendo analizados con el objetivo de encontrar formas de intervención y prevención. Dichas aproximaciones son muy prometedoras, por las siguientes razones:

>Ya están respaldadas por pruebas científicas de concepto, involucrando un evidente incremento en la expectativa de vida de modelos animales y las crecientes capacidades tecnológicas de intervenir en el proceso fundamental de envejecimiento [12,18-23].

>Pueden proveer soluciones a un número de enfermedades intransmisibles ligadas al envejecimiento, en la medida en que dichas enfermedades están fuertemente determinadas por procesos degenerativos del envejecimiento (como la inflamación crónica, enlazamiento cruzado de macromoléculas, mutaciones somáticas, pérdida de poblaciones de células germinales, y otras) [24-28]. Más aún, es probable que disminuyan la susceptibilidad de los adultos mayores a las enfermedades transmisibles debido a mejoras en inmunidad [29].

>Los innovadores, resultados aplicados de dichas investigaciones y desarrollos llevarán a soluciones sostenibles para un largo campo de desafíos médicos y relacionados con la edad, que pueden ser aplicados globalmente.

>Dichas investigaciones y desarrollos debieran ser apoyados en fundamentos éticos, para proveer iguales posibilidades de cuidados médicos para los mayores y los jóvenes.

Por lo tanto, es el deber social, especialmente de los profesionales en biología, medicina, cuidado de salud, economía y organizaciones socio-políticas recomendar fuertemente mayor inversión, investigación, y desarrollo que se dedique a entender los mecanismos asociados con el proceso biológico del envejecimiento humano y traducir esos descubrimientos a tecnologías y tratamientos seguros, baratos, y universalmente disponibles.

Por consiguiente, puedan haber grandes beneficios para la sociedad, la economía y en general nuestra calidad de vida en priorizar y acelerar la investigación, desarrollo e innovación en este campo, incluyendo los siguientes:

  • Medicina Regenerativa – Incluyendo el desarrollo de tecnologías de células madres y sus productos derivativos, regeneración de órganos y tejidos in vivo y ex vivo, muerte celular inducida, immuno-eliminación de células senescentes o cancerosas.
  • Ingeniería de Tejidos – Cultivación y amalgamación de un amplia variedad de órganos y tejidos para reemplazamiento, vasculares y no vasculares, usando métodos como la impresion tridimensional, andamios biodegradables, bioreactores o auto-organización.
  • Regulación de la homeostasis en todo el cuerpo, incluyendo reguladores del ritmo circadiano, neurohumoral y reguladores moleculares.
  • Substancias gerontoprotectoras – Por ejemplo, anti-glucémicas, estatinas, anticoagulantes, antioxidantes,  moduladores de hormonas, moduladoras de mitocondria, anti-inflamatorias, y medicamentos probióticos y biorreguladores.
  • Detoxificación al nivel celular y molecular – Por ejemplo, quelantes, enterosorbentes, digestores de productos finales de glicación avanzada (AGE-breakers), Secuestro y despeje immune, secuestro y despeje enzimático, etc.
  • Suplementacion Dietetica  – Establecimiento de requisitos nutritivos en la dieta de personas de edad avanzada y durante el curso de vida entero, por ejemplo, el uso de suplementación con vitaminas, microelementos, macroérgicos.
  • Terapia Génetica – Ingeniería genética segura y estimulación farmacológica de “genes de longevidad” (por ejemplo Sirtuins y FOXO), atenuación de “Factores Acelerantes de Decaimiento”, manipulación de vías genéticas promovedoras de longevidad (por ejemplo la via mTOR), estimulación de la actividad de la telomerasa, interferencia en ARN, secuenciación y cribado de longevidad genetica y epigenetica.
  • Nanomedicina – Por ejemplo, nanopartículas para la administracion farmaceutica, prototipos emergentes de inmunidad artificial y de micro- y nano-dispositivos suministrantes  de oxígeno, y potencialmente dispositivos para la reparación de tejidos macromolecular.
  • Reemplazamiento con órganos artificiales e interfaces y estimulación electrofisiológica  – Por ejemplo, prótesis funcionales de órganos y extremidades, neuroprótesis, avanzadas interfaces cerebro-computadora, estimulación electrofisiológica de funciones atrofiadas  neurológicas y musculares.
  • “Yo Cuantificado” – Automonitoreo comprensivo y diagnosis personalizado de vitalidad y condiciones ligadas al envejecimiento, calculados regimens para una balanceada y saludable nutrición y suficiente actividad física para las personas de edad avanzada.
  • Mineria de Datos – Grandes analiticas sobre datos de salud, descubrimiento de efectivas intervenciones candidatas, modelos formales y cuantitativos y ademas visualmente accesibles e interactivos de los procesos y enfermedades del envejecimiento y de intervenciones anti-edad.
  • Cryopreservation y quimiopreservacion – beneficiosa para la trasplantación de órganos y tejidos, y para un conocimiento más profundo en cuanto a la fisiología del envejecimiento.

Abordar procesos debilitantes ligados al envejecimiento a través de medios biomédicos debe convertirse en un innovador y poderoso  enfoque y un estándar médico para la prevención de enfermedades intransmisibles, las cuales afectan mayormente las personas en etapas de vida avanzadas. El proposito de la medicina preventiva para los ancianos, usando tecnologías biomédicas avanzadas, es preservar la salud de una persona en envejecimiento para prevenir el deterioro funcional.

Los gobiernos deben asegurar la creación y la implementación de las siguientes políticas para promover la investigación de la biología del envejecimiento y enfermedades ligadas al envejecimiento, con fin de mejorar la salud de la población global de edad avanzada.

1)               Financiamiento:

  • Asegurar un significante incremento del financiamiento gubernamental y no gubernamental para investigaciones orientadas hacia las metas (translacionales) de prevenir los procesos del envejecimiento degenerativo, y las asociadas enfermedades crónicas intransmisibles, y extender la salud y productividad de vida durante la totalidad de su transcurso.

Especificamente:

  • Dedicar un porcentaje presupuestal asignado dentro de ministerios relevantes, por ejemplo, ministros de salud y/o de ciencia, particularmente las divisiones referentes a la investigación y el tratamiento de enfermedades crónicas intransmisibles.
  • Dedicar un porcentaje específico del rendimiento de las ganancias comerciales de compañías farmacéuticas, biotecnológicas, y de tecnología médica para dicha investigación y desarrollo.
  • Establecer relevantes subvenciones para la investigación a base de competencia y dirigidas hacia el objetivo.
  • Duplicación del financiamiento para semejantes investigaciones cada 5 años por los siguientes 20 años.

2)               Incentivos:

  • Desarrollar y adoptar marcos legales y reguladores que den incentivas para investigaciones y desarrollo dirigidos a los objetivos, y diseñados específicamente para abordar el desarrollo, registración, administración y disponibilidad de drogas, tecnologías médicas y otras terapias que aminoran los procesos del envejecimiento y sus ligadas enfermedades, y extienden la vida.

Especificamente:

  • Desarrollar criterio en cuanto la eficacia y seguridad de terapias gerontoprotectivas.
  • Facilitar experimentos in silico y en animales, y experimentación ética en humanos y con seguridad reforzada.
  • Desplegar y asegurar terapias gerontoprotectivas en el estado de terapias auxiliares con potencial de extender de vida.
  • Proveer una via de aprobación abreviada para terapias con alto nivel de evidencia de eficacia en estudios preclínicos y los primeros estudios clínicos, y además en casos de condiciones de degeneración avanzada o aparentemente fútiles.
  • Conceder reconocimiento especial, reputación y beneficios a entidades comerciales y públicas dedicadas a tales investigaciones y desarrollo.

3)               Instituciones:

  • Establecer y expandir coordinación y estructuras de consultación nacionales e internacionales, programas e instituciones que dirigen la promoción de investigación, desarrollo y educación sobre la biología del envejecimiento y ligadas enfermedades y el desarrollo de directrices clínicas para modular los procesos del envejecimiento y enfermedades ligadas y extender el transcurso de vida saludable y productivo para la población.

Especificamente:

  • Establecer especializaciones en biogerontología ademas de cursos de biogerontología como currículo común en universidades.
  • Desarrollar y diseminar regímenes gerontoprotectivos, basado en la mejor evidencia disponible, como parte de recomendaciones de salud autoritativas.
  • Establecer centros cooperativos de excelencia para estudios fundamentales, transnacionales y aplicados, ademas de centros para el análisis estratégico, pronóstico, educación y desarrollo de políticas sobre el envejecimiento y la investigación de la longevidad, en instituciones académicas y variadas agencias gubernamentales y supra-gubernamentales.

Estas medidas están diseñadas para reducir la carga de lo procesos del envejecimiento sobre la economía y aliviar el sufrimiento de los envejecidos y el dolor emocional de sus seres queridos. Por el lado positivo, si se recibe suficiente apoyo, estas medidas pueden incrementar la expectativa de una vida saludable en las personas de edad avanzada, extendiendo su periodo de  productividad, su intercambio con la sociedad, y ampliando su posibilidad de disfrutar la vida, ademas de su sentido de propósito, igualdad, y valoración.

[30].

Sociedad Internacional Sobre Envejecimiento y Enfermedades (ISOAD)

Comite Ejecutivo:

Prof. Kunlin Jin. Department of Pharmacology and Neuroscience, University of North Texas, Health Science Center. Fort Worth, Texas, EE.UU. Presidente de ISOAD

Email: kunlin.jin@unthsc.edu

Prof. James W. Simpkins. Center for Basic and Translational Stroke Research, West Virginia University. Morgantown, West Virginia, EE.UU.  Director de ISOAD

Email: jwsimpkins@hsc.wvu.edu

Prof. Xunming Ji. Department of Neurosurgery, Xuanwu Hospital, Capital Medical University. Beijing (Pekín), China.  Vice-Presidente de ISOAD

Email: jixunming@vip.163.com

Dr. Miriam Leis. Fraunhofer Society for the Advancement of Applied Research. Munich, Germany. Asesora en Póliza de ISOAD

Email: miriam.leis@zv.fraunhofer.de

Dr. Ilia Stambler. Department of Science, Technology and Society, Bar Ilan University. Ramat Gan, Israel. Coordinador de Alcance de ISOAD

Email: ilia.stambler@gmail.com

Traducción: Cristopher Rosales Navarro, Seb Restrepo, Luren Canales Costa, Keyla Ortiz, Oscar Eduardo Juez, Adrian Correa.

Referencias

[1] World Health Organization (2014). World Health Statistics – Large Gains in Life Expectancy. Accessed December 2014. Retrieved from: http://www.who.int/mediacentre/news/releases/2014/world-health-statistics-2014/en/.

[2] Human Mortality Database. Accessed December 2014. Retrieved from: http://www.mortality.org.

[3] United Nations, Department of Economic and Social Affairs, Population Division (2011). World Population Prospects: The 2010 Revision, CD-ROM Edition. Accessed December 2014. Retrieved from: http://esa.un.org/wpp/.

[4] World Health Organization (2013). Draft Twelfth General Programme of Work. Accessed December 2014. Retrieved from: http://www.who.int/about/who_reform/programme_priority/en/.

[5] World Health Organization (2014). Ageing and Life Course. Accessed December 2014. Retrieved from:http://www.who.int/ageing/en/.

[6] United Nations, Department of Economic and Social Affairs, Population Division (2013). World Population Aging Report. Accessed December 2014. Retrieved from: http://www.un.org/en/development/desa/population/.

[7] The International Longevity Center Global Alliance (2010). Global Aging Report. Threats to Longevity. A Call to Action. Accessed December 2014. Retrieved from: http://www.ilc-alliance.org/index.php/reports/.

[8] Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. (2012). Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 380:2095-2128.

[9] Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. (2012). A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010, Lancet, 380:2224-2260.

[10] Kennedy BK, Berger SL, Brunet A, Campisi J, Cuervo AM, Epel ES, et al. (2014). Geroscience: linking aging to chronic disease. Cell, 59:709-713.

[11] Healthspan Campaign (2013). NIH Geroscience Interest Group (GSIG) Releases Recommendations from the October 2013 Advances in Geroscience Summit. Accessed December 2014. Retrieved from:http://healthspancampaign.org/2014/02/27/nih-geroscience-interest-group-gsig-releases-recommendations-october-2013-advances-geroscience-summit/

[12] Fahy GM, West MD, Coles LS, Harris SB (Eds). The Future of Aging: Pathways to Human Life Extension. New York: Springer; 2010.

[13] Fontana L, Kennedy BK, Longo VD, Seals D, Melov S (2014). Medical research: treat ageing. Nature, 511:405-407.

[14] López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G (2013). The hallmarks of aging. Cell, 153:1194-1217.

[15] De Grey ADNJ, Rae M. Ending Aging. The Rejuvenation Breakthroughs That Could Reverse Human Aging in Our Lifetime. New York: St. Martin’s Press; 2007.

[16] Goldman DP, Cutler D, Rowe JW, Michaud PC, Sullivan J, Peneva D, Olshansky SJ (2013). Substantial health and economic returns from delayed aging may warrant a new focus for medical research. Health Aff, 10:1698-1705.

[17] Rae MJ, Butler RN, Campisi J, de Grey ADNJ, Finch CE, Gough M, et al. (2010). The demographic and biomedical case for late-life interventions in aging. Sci Transl Med, 2:40cm21.

[18] Kanfi Y, Naiman S, Amir G, Peshti V, Zinman G, Nahum L, et al. (2012). The sirtuin SIRT6 regulates lifespan in male mice. Nature, 483:218-221.

[19] Atala A. Extending life using tissue and organ replacement (2008). Curr Aging Sci, 1:73-83.

[20] Baati T, Bourasset F, Gharbi N, Njim L, Abderrabba M, Kerkeni A, et al. (2012). The prolongation of the lifespan of rats by repeated oral administration of [60] fullerene. Biomaterials, 33:4936-4946.

[21] Kheir JN, Scharp LA, Borden MA, Swanson EJ, Loxley A, Reese JH, et al. (2012). Oxygen gas-filled microparticles provide intravenous oxygen delivery. Sci Transl Med, 4:140ra88.

[22] Shawn M. Douglas SM, Bachelet I, Church GM (2012). A logic-gated nanorobot for targeted transport of molecular payloads. Science, 335:831-834.

[23] Kennedy BK, Pennypacker JK (2014). Drugs that modulate aging: the promising yet difficult path ahead. Transl Res, 163:456-465.

[24] Chung HY, Cesari M, Anton S, Marzetti E, Giovannini S, Seo AY, et al. (2009). Molecular inflammation: Underpinnings of aging and age-related diseases. Ageing Res Rev, 8:18-30.

[25] Lunn JS, Sakowski SA, Hur J, Feldman EL (2011). Stem cell technology for neurodegenerative diseases. Ann Neurol, 70:353-361.

[26] Baylis D, Bartlett DB, Patel HP, Roberts HC (2014). Understanding how we age: insights into inflammaging. Longev Healthspan, 3:6.

[27] Dai DF, Chiao YA, Marcinek DJ, Szeto HH, Rabinovitch PS (2014). Mitochondrial oxidative stress in aging and healthspan. Longev Healthspan, 3:6.

[28] Zieman S, Kass D (2004). Advanced glycation end product cross-linking: Pathophysiologic role and therapeutic target in cardiovascular disease. Congest Heart Fail, 10:144-149.

[29]  Bredenkamp N, Nowell CS, Blackburn CC (2014). Regeneration of the aged thymus by a single transcription factor. Development, 141:1627-1637.

[30] This position paper of the International Society on Aging and Disease (ISOAD) was published on behalf of the ISOAD Executive Committee as: Kunlin Jin, James W. Simpkins, Xunming Ji, Miriam Leis, Ilia Stambler (2015). The critical need to promote research of aging and aging-related diseases to improve health and longevity of the elderly population. Aging Disease, 6(1):1-5

http://www.aginganddisease.org/EN/10.14336/AD.2014.1210

 

A History of Life-Extensionism in the Twentieth Century

HISTORY LONGEVITY PICTURE

A History of Life-Extensionism in the Twentieth Century

By Ilia Stambler, PhD

A book on the history of Aging and Life Extension research, freely available online at:

http://www.longevityhistory.com/

And as a hard copy at:

http://www.amazon.com/History-Life-Extensionism-Twentieth-Century/dp/1500818577/

Proceedings from the sales of this book will be donated to international longevity research and advocacy projects, such as Israeli Longevity Alliance http://www.bioaging.org.il/ , Longevity for All http://www.longevityforall.org/ and others, or used to distribute more free copies to centers of learning around the world to increase education on aging and longevity research http://www.longecity.org/forum/topic/75826-donation-of-books-on-life-extension-to-university-libraries/

You can find more information on the subject at:

http://www.longevityhistory.com/ and  https://www.facebook.com/LongevityHistory

Thank you for your interest and feedback!

The book Summary:

This work explores the history of life-extensionism in the 20th century. The term life-extensionism is meant to describe an ideological system professing that radical life extension (far beyond the present life expectancy) is desirable on ethical grounds and is possible to achieve through conscious scientific efforts.

This work examines major lines of life-extensionist thought, in chronological order, over the course of the 20th century, while focusing on central seminal works representative of each trend and period, by such authors as Elie Metchnikoff, Bernard Shaw, Alexis Carrel, Alexander Bogomolets and others. Their works are considered in their social and intellectual context, as parts of a larger contemporary social and ideological discourse, associated with major political upheavals and social and economic patterns.

The following national contexts are considered: France (Chapter One), Germany, Austria, Romania and Switzerland (Chapter Two), Russia (Chapter Three), the US and UK (Chapter Four).

This work pursues three major aims.

The first is to attempt to identify and trace throughout the century several generic biomedical methods whose development or applications were associated with radical hopes for life-extension. Beyond mere hopefulness, this work argues, the desire to radically prolong human life often constituted a formidable, though hardly ever acknowledged, motivation for biomedical research and discovery. It will be shown that novel fields of biomedical science often had their origin in far-reaching pursuits of radical life extension. The dynamic dichotomy between reductionist and holistic methods will be emphasized.

The second goal is to investigate the ideological and socio-economic backgrounds of the proponents of radical life extension, in order to determine how ideology and economic conditions motivated the life-extensionists and how it affected the science they pursued. For that purpose, the biographies and key writings of several prominent longevity advocates are studied. Their specific ideological premises (attitudes toward religion and progress, pessimism or optimism regarding human perfectibility, and ethical imperatives) as well as their socioeconomic conditions (the ability to conduct and disseminate research in a specific social or economic milieu) are examined in an attempt to find out what conditions have encouraged or discouraged life-extensionist thought. This research argues for the inherent adjustability of life-extensionism, as a particular form of scientific enterprise, to particular prevalent state ideologies.

The third, more general, aim is to collect a broad register of life-extensionist works, and, based on that register, to establish common traits and goals definitive of life-extensionism, such as valuation of life and constancy, despite all the diversity of methods and ideologies professed. This work will contribute to the understanding of extreme expectations associated with biomedical progress that have been scarcely investigated by biomedical history.

May 15, 2015 – 170th anniversary of Elie Metchnikoff – the founder of gerontology – an opportunity to promote aging and longevity research

METCHNIKOFF FOR SITEMay 15, 2015 – 170th anniversary of Elie Metchnikoff – the founder of gerontology – an opportunity to promote aging and longevity research

On May 15, 2015, we celebrate the 170th anniversary of the founder of gerontology, a foundational figure of modern immunology, aging and longevity science, and of modern medicine generally – Elie Metchnikoff (May 15, 1845 – July 15, 1916). For the proponents of healthy longevity and advocates of aging research, Metchnikoff has a special significance. Metchnikoff is of course known as a pioneering immunologist and microbiologist, a vice director of the Pasteur Institute in Paris, and the Nobel Laureate in Physiology or Medicine of 1908 for the discovery of phagocytosis (a major contribution to the cellular theory of immunity). Yet, he may also be well credited as “the father” of gerontology – the disciplinary term he coined. Both the terms “gerontology” (“the study of aging”) and “thanatology” (“the study of death”) were coined by him in the Etudes On the Nature of Man,published in 1903, which may mark the beginning of these scientific fields. To the present day, his scientific reputation has remained high around the world. In fact, Metchnikoff can be considered a unifying cultural symbol for many nations.

There is a tradition to celebrate the anniversaries of great persons (scientists, artists, writers, politicians, generals) to promote the area of their activity and popularize their ideology. It may be hoped that, in this year, the anniversary of Metchnikoff will serve to promote and popularize the science and ideology of healthy life extension, including the state level. The “Metchnikoff Day” can provide an impulse for organizing topical meetings and conferences, a stimulus for research, and publications in the media, dedicated to Metchnikoff’s legacy and continuation of his life work – the study of aging and longevity. This may play a positive role not only for the advancement and popularization of research of aging and healthy longevity, but also for the promotion of optimism, peace and cooperation.

Currently events in honor of the Metchnikoff Day are being planned in Kiev, Ukraine, on behalf of the Kiev Institute of Gerontology of the Ukrainian Academy of Medical Sciences; St. Petersburg, Russia, on behalf of the Gerontological Society of the Russian Academy of Sciences and I.I. Mechnikov North-Western State Medical University; in Moscow on behalf of the National Research Center for Preventive Medicine of the Ministry of Healthcare of the Russian Federation, and further meetings in Moscow are planned by several public organizations, including the Fedorov Movement, the Russian Transhumanist Movement and the Russian Longevity Alliance; Larnaca, Cyprus, on behalf of the ELPIs Foundation and the Cyprus Neuroscience and Technology Institute; Oxford, UK, on behalf of the Oxford University Scientific Society and Biogerontology Research Foundation; in Ramat Gan, in Bar Ilan University, Israel, on behalf of the Israeli Longevity Alliance and the International Society on Aging and Disease (Israeli branch).

It may be hoped that, following these examples, more events and publications, dedicated to research of aging and longevity, will be held around the world in honor of this day or close to it. Thus thanks to Metchnikoff’s continuing inspiration and authority, the interest in aging and longevity research will be increased in all the walks and segments of society.

There is little time left until May 15, perhaps enough to prepare a small publication or meeting, live or online. Yet Metchnikoff’s authority may help us promote the study of aging and longevity also in the next year – July 15, 2016 is the 100th anniversary of Metchnikoff’s death, which can also become an impulse toward meetings and publications, with a greater time for preparation. The organization of several connected events in different countries in the same day (or period) in the framework of an international action, may produce a synergistic, mutually reinforcing effect.  Yet, of course, those are not the only days that could be used for such an effect. An additional convenient day (or period) to conduct an international action in support of aging and longevity research, can be October 1, 2015 – the day officially sanctioned by the UN as the “International Day of Older Persons” (celebrated by some parts of the longevity advocacy community as  the “International Longevity Day”). In 2013-2014, events around that day were conducted by various longevity activists groups, public organizations and scientific centers in tens of countries.

http://www.longevityforall.org/october-1-international-day-of-older-persons-longevity-day-2013-2014/

We hope that thanks to our mutual efforts, from above and from below, thanks to the events, organized on those and other days – the need to promote research of aging and aging-related diseases to improve health and longevity of the elderly population – will be recognized by all parts of society, including the broad public, the professional and scientific community, and decision makers, and will stimulate actions corresponding to the severity and urgency of the problem.

http://www.longevityforall.org/the-critical-need-to-promote-research-of-aging-around-the-world/

Thank you for your support!

See also a fuller announcement, including the description of the foundational role of Metchnikoff for the formation of modern science of aging and longevity and a list of events that are being organized in honor of that day (the list will be updated)

http://www.longevityforall.org/170th-anniversary-of-elie-metchnikoff-the-founder-of-gerontology-may-15-2015/

And a copy of this announcement

http://www.longevityforall.org/may-15-2015-170th-anniversary-of-elie-metchnikoff-the-founder-of-gerontology-an-opportunity-to-promote-aging-and-longevity-research/

 

Dr. IliaStambler

OutreachCoordinator. International Society on Aging and Disease (ISOAD)

Department of Science, Technology and Society. Bar Ilan University. Israel

ilia.stambler@gmail.com

972-3-961-4296
http://isoad.org/
http://www.longevityforall.org/
http://www.bioaging.org.il/
http://www.longevityhistory.com

 

 

The Critical Need to Promote Research of Aging Around the World

logo-ISOAD

Below is the position paper on the Critical Need to Promote Research of Aging of the International Society on Aging and Disease (ISOAD http://isoad.org/). This paper briefly details the rationales, the technologies and the policies that are needed to promote this research. Thus it can serve as a generally applicable advocacy or lobbying paper in different countries. Please help spread it. Please contribute to the widest possible recognition and support of biological research of aging and aging-related diseases. We welcome the readers to circulate this position paper, share it in your social networks, forward it to politicians, potential donors and media, organize discussion groups to debate the topics raised (that may later grow into grassroots longevity research and activism groups in different countries), translate this position paper into your language, reference and link to it, even republish it in part or in full (for example, the policy recommendations can fit on a single page flyer), join the ISOAD or other aging and longevity research and advocacy organizations.

Originally published in the ISOAD journal Aging and Disease, 6 (1), 2015 http://www.aginganddisease.org/EN/10.14336/AD.2014.1210

The position Paper now appears in full or part in 12 languages, beside English below,  also in Chinese, Russian, Hebrew, Arabic, German, Italian, Spanish, Portuguese, Danish, Finnish, Swedish:

English http://www.longevityforall.org/the-critical-need-to-promote-research-of-aging-around-the-world/

Chinese http://www.longevityforall.org/the-need-to-promote-aging-research-chinese/

Russian http://www.longevityforall.org/the-need-to-promote-aging-research-russian/

Hebrew http://www.longevityforall.org/the-need-to-promote-aging-research-hebrew/

Arabic http://www.longevityforall.org/the-need-to-promote-aging-research-arabic/

German http://www.longevityforall.org/need-to-promote-aging-research-german/

Italian http://www.longevityforall.org/the-need-to-promote-aging-research-italian/

Spanish: http://www.longevityforall.org/the-need-to-promote-aging-research-spanish/

Portuguese http://www.longevityforall.org/the-need-to-promote-aging-research-portuguese/

Partial (summary) translations:

Danish: http://www.longevityforall.org/det-kritiske-behov-for-at-fremme-forskning-omkring-aeldning/

Finnish: http://www.longevityforall.org/nordic-longevity-outreach-finnish/

Swedish: http://www.longevityforall.org/det-akuta-behovet-av-att-framja-forskning-om-aldrande/

 

The Critical Need to Promote Research of Aging and Aging-related Diseases to Improve Health and Longevity of the Elderly Population

 

Summary

 

Due to the aging of the global population and the derivative increase in aging-related non-communicable diseases and their economic burden, there is an urgent need to promote research on aging and aging-related diseases as a way to improve healthy and productive longevity for the elderly population. To accomplish this goal, we advocate the following policies: 1) Increasing funding for research and development specifically directed to ameliorate degenerative aging processes and to extend healthy and productive lifespan for the population; 2) Providing a set of incentives for commercial, academic, public and governmental organizations to foster engagement  in such research and development; and 3) Establishing and expanding coordination and consultation structures, programs and institutions involved in aging-related research, development and education in academia, industry, public policy agencies and at governmental and supra-governmental levels.

 

The challenge of the aging society and potential solutions

 

Over the past decades, the average life expectancy has increased globally, reaching a world-wide average of about 70 years in 2014 (6 years longer than in 1990) and around 80 in the developed countries (compared to about 50 years in the developed countries in the early 20th century).  This development has been achieved especially due to improvements in sanitation, medical advances, rising living standards and a decline in child mortality. Currently, while the longest life expectancies are still found in the “developed” countries, the fastest and largest increase has been recorded in the “developing” world. Considering the demographics of the world population, between 2000 and 2050 the proportion of people over 60 years will double from about 11% to 22%, which, in absolute terms, means an increase from 605 million to 2 billion people [1-3].

Although the increasing life expectancy generally reflects positive human development, new challenges are arising. They stem from the fact that growing older is still inherently associated with biological and cognitive degeneration, although the severity and speed of cognitive decline, physical frailty and psychological impairment can vary between individuals.

Nonetheless, degenerative aging processes are the major underlying cause for non-communicable diseases (NCDs), including cancer, ischemic heart disease, stroke, type 2 diabetes, Alzheimer’s disease and others. Mental health deterioration due to chronic neurodegenerative diseases represents the largest cause of disability in the world, responsible for over 20% of years lived with disability. Hence major efforts must be directed toward their alleviation. According to the World Health Organization’s (WHO) “Draft Twelfth General Programme of Work” (April 13, 2013), one of WHO leadership priorities is “Addressing the challenge of non-communicable diseases” [4], and addressing aging fits into this definition and is even necessary to accomplish this priority goal.

Aging also increases the risk of morbidity and mortality from infectious diseases like pneumonia and influenza. Moreover, the susceptibility to injury and trauma (such as falls and concussions), due to the impairment of balance and mental state, and even falling victim to violence, are strongly increased by the aging process. Also, the processes of aging exacerbate and reinforce the effects of other risk factors of non-communicable diseases (tobacco use, unhealthy diet, physical inactivity, and harmful use of alcohol). In sum, aging-related health decline is the major cause of mortality and morbidity worldwide and should be addressed according to the severity of the problem. Because of these severe and negative effects, aging is already regarded as one of the greatest economic and societal challenges that most countries – especially in the industrialized world – will face in the coming decades.

Several reports from national governments, international organizations, such as the United Nations (UN) and WHO, as well as insurance companies, welfare organizations and non-governmental organizations (NGOs), have referred to the socio-economic and health-related challenges of aging societies [5-9]. These include:

  • Increases of health care costs and financial stress for social insurance systems due to the increasing probability of suffering from diseases associated with aging.
  • Dementia is often mentioned as especially problematic since it additionally requires intensive care-giving, imposing a heavy burden on working relatives or demanding significant additional costs for the provision of professional care.
  • A declining active workforce is already occurring, especially in industrialized countries. Although people might want to participate in the workforce for a longer time, they may not be able to, due to cognitive and physical decline.
  • An increasing number of pensioners need to be financed, while a larger number of working people need to provide care services that must remain affordable.
  • There are considerable concerns over the quality of life and health status of the elderly due to age-related diseases, biological degeneration and increased risk of succumbing to severe chronic and life-threatening conditions.
  • An overall decline in the quality of life deprives many elderly from full social, cultural and intellectual engagement.

The challenge of the aging society has been widely recognized and numerous research and development programs around the globe have been initiated to tackle age-related diseases, such as the Campaign to Prevent Alzheimer’s Disease and/or WHO Diabetes Prevention Program, as well as to develop care-related technologies such as care robots, fall detectors and technologies for Ambient Assisted Living (AAL) or making housing and infrastructure more friendly and accessible to the elderly. Although such investments are laudable and understandable, given the urgency of the problem, they all represent only punctual and rather ad hoc solutions.

In particular, assistive technologies, infrastructural changes or improving nursing and palliative care facilities, do not solve the actual problem of biological degeneration associated with the aging process.  Medical research and development efforts currently are focused mainly on single diseases, like Alzheimer’s dementia, heart disease, osteoporosis, diabetes, cancer, etc. The underlying degenerative aging processes, determinative for the emergence of those diseases, are often underemphasized.

While the degenerative aging process, involving the accumulation of structural damage, impairment of metabolic balance and functioning, is a disabling and debilitating process that requires prevention and treatment, the achievement of healthy longevity, characterized by the maintenance of functional capacity and robustness, is its cure.

Some effects of degenerative aging processes can be modified by social and economic factors, as well as lifestyles (diet, exercise, etc.), but only to a modest extent. Hence, there is a need to promote research into the biology of aging and aging-related diseases as the way to improve the health of the elderly more substantially.

New directions in research and development take a more holistic approach for tackling the degenerative processes and negative biological effects of human aging, addressing several major fundamental causes of aging and aging-related diseases at once and in an interrelated manner. For example, at the 2013 US National Institutes of Health (NIH) Geroscience Summit, the following priority research areas have been identified: Adaptation to Stress, Epigenetics, Inflammation, Macromolecular Damage, Metabolism, Proteostasis, and Stem Cells/Regeneration [10,11], but there are several other examples of similar approaches, prioritizing research of major sets of aging processes [12-17]. Instead of targeting single age-related diseases, the mechanisms of the aging process itself are being analyzed with the goal of finding ways for intervention and prevention.

Such approaches are very promising, for the following reasons:

  • They are already supported by scientific proofs of concept, involving the evidential increase in healthy lifespan in animal models and the emerging technological capabilities to intervene into fundamental aging processes [12,18-23].
  • They can provide solutions to a number of non-communicable, age-related diseases, insofar as such diseases are strongly determined by degenerative aging processes (such as chronic inflammation, cross-linkage of macromolecules, somatic mutations, loss of stem cell populations, and others) [24-28]. Moreover, they are likely to decrease susceptibility of the elderly also to communicable diseases due to improvements in immunity [29].
  • The innovative, applied results of such research and development will lead to sustainable solutions for a large array of age-related medical and social challenges, that may be globally applicable.
  • Such research and development should be supported on ethical grounds, to provide equal health care chances for the elderly as for the young.

Therefore it is the societal duty, especially of the professionals in biology, medicine, health care, economy and socio-political organizations to strongly recommend greater investments in research and development dealing with the understanding of mechanisms associated with the human biological aging process and translating these insights into safe, affordable and universally available applied technologies and treatments.

Thus there may be great benefits for society, the economy and our overall quality of life to prioritize and accelerate the research, development and innovation in the field, including the following:

  • Regenerative medicine – including the development of stem cell technologies and their products, in vivo and ex vivo regeneration of organs and tissues; controlled cell death, immuno-elimination of senescent or cancer cells.
  • Tissue engineering – culturing and assembling of a wide variety of replacement organs and tissues, vascular and non-vascular, using such methods as 3D tissue printing, biodegradable scaffolding, bioreactors or self-organization.
  • Regulation of whole body homeostasis, including regulators of the circadian rhythm, neurohumoral and molecular bioregulators.
  • Geroprotective substances – e.g. anti-glycemic, statins, anti-coagulant, anti-oxidant, hormone-modulating, mitochondria-modulating, anti-inflammatory, probiotic and bioregulating medications.
  • Detoxification at the cellular and molecular level – e.g. chelators, enterosorbents, AGE-breakers, oxido-reductive depolymerization, immunoclearance, enzymatic clearance, etc.
  • Dietary supplementation – establishing dietary nutrient requirements for the elderly and during the entire life-course, e.g. using supplementation with vitamins, microelements, macroergics.
  • Gene therapy and gene modulation – e.g. safe genetic engineering, epigenetic and pharmacological stimulation of “Longevity Genes” (e.g. Sirtuins and FOXO), attenuation of “Decay Accelerating Factors” (DAF), manipulation of longevity promoting genetic pathways (e.g. mTOR pathway), stimulation of telomerase activity, RNA interference, genetic and epigenetic longevity sequencing and screening.
  • Nanomedicine – e.g. nanoparticles for drug delivery, emerging prototypes of artificial immunity and oxygen supply micro- and nano-devices, potentially devices for macromolecular tissue repair.
  • Artificial organ replacement and electrophysiological interfaces and stimulation – e.g. functional organ and limb prostheses, neuro-prostheses, advanced brain-computer interfaces, electrophysiological stimulation of impaired neurological and muscle functions.
  • Quantified self – comprehensive self-monitoring and personalized diagnosis of vitality and age-related conditions, calculating regimens for balanced and healthy nutrition and sufficient physical activity for the aged.
  • Data mining – large health data analytics, discovering effective candidate interventions, formal and quantitative as well as visually accessible and interactive models of aging processes and diseases and anti-aging interventions.
  • Cryopreservation and chemopreservation – beneficial for organ or tissue transplantation and for a deeper insight into the physiology of aging.

 

Addressing aging-related debilitating processes through such biomedical means should become a new and powerful approach and medical standard for the prevention of non-communicable diseases, which affect most people at the later stages of life. The purpose of preventive medicine for the elderly, using advanced biomedical technologies, is to preserve health of an aging individual so as to prevent functional decline.

 

Governments should ensure the creation and implementation of the following policies to promote research into the biology of aging and aging-related diseases, for improving the health of the global elderly population:

 

1)               Funding:

  • Ensuring a significant increase of governmental and non-governmental funding for goal-directed (translational) research in preventing the degenerative aging processes, and the associated chronic non-communicable diseases and disabilities, and for extending healthy and productive life, during the entire life course.

           Specifically:

  • Dedicating a designated percentage of budget within relevant ministries, such as ministries of health and/or science, particularly in the divisions concerning research and treatment of non-communicable chronic diseases.
  • Dedicating a specific percentage of the profits of commercial pharmacological, biotechnology and medical technology companies to such research and development.
  • Establishing relevant research grant programs on a competitive as well as goal-directed basis.
  • Doubling of funding for such research every 5 years for the next 20 years.

 

2)               Incentives:

  • Developing and adopting legal and regulatory frameworks that give incentives for goal-directed research and development designed to specifically address the development, registration, administration and accessibility of drugs, medical technologies and other therapies that will ameliorate the aging processes and associated diseases and extend healthy life.

           Specifically:

  • Developing criteria for efficacy and safety of geroprotective therapies.
  • Facilitating in silico and animal testing, and ethical safety-enhanced human testing of such therapies.
  • Deploying and ensuring geroprotective therapies in the status of adjuvant and life-extending therapies.
  • Providing a shortened approval pathway for therapies with high level of efficacy evidence in preclinical and early clinical trials, as well as in cases of advanced degenerative and seemingly futile conditions.
  • Granting a special recognition, status and benefits to commercial and public entities engaged is such research and development.

 

3)               Institutions:

  • Establishing and expanding national and international coordination and consultation structures, programs and institutions to steer promotion of research, development and education on the biology of aging and associated diseases and the development of clinical guidelines to modulate the aging processes and associated aging-related diseases and to extend the healthy and productive lifespan for the population.

           Specifically:

  • Establishing Biogerontology specialty and courses in Biogerontology as a common part of university curriculum.
  • Developing and disseminating geroprotective regiments, based on the best available evidence, as part of authoritative health recommendations.
  • Establishing cooperative centers of excellence for fundamental, translational and applied studies, alongside centers for strategic analysis, forecast, education and policy development on aging and longevity research, at academic institutes and various governmental and supra-governmental agencies.

 

These measures are designed to reduce the burden of the aging process on the economy and to alleviate the suffering of the aged and the grief of their loved ones. On the positive side, if granted sufficient support, these measures can increase the healthy life expectancy for the elderly, extend their period of productivity and their interaction with society, and enhance their sense of enjoyment, purpose, equality and valuation of life [30].

 

 

International Society on Aging and Disease (ISOAD)

 

Executive Committee:

 

Prof. Kunlin Jin. Department of Pharmacology and Neuroscience, University of North Texas, Health Science Center. Fort Worth, Texas, USA. ISOAD Chair

Email: kunlin.jin@unthsc.edu

 

Prof. James W. Simpkins. Center for Basic and Translational Stroke Research, West Virginia University. Morgantown, West Virginia, USA. ISOAD President

Email: jwsimpkins@hsc.wvu.edu

 

Prof. Xunming Ji. Department of Neurosurgery, Xuanwu Hospital, Capital Medical University. Beijing, China. ISOAD Vice Chair

Email: jixunming@vip.163.com

 

Dr. Miriam Leis. Fraunhofer Society for the Advancement of Applied Research. Munich, Germany. ISOAD Policy Advisor

Email: miriam.leis@zv.fraunhofer.de

 

Dr. Ilia Stambler. Department of Science, Technology and Society, Bar Ilan University. Ramat Gan, Israel. ISOAD Outreach Coordinator

Email: ilia.stambler@gmail.com

 

 

References

[1] World Health Organization (2014). World Health Statistics – Large Gains in Life Expectancy. Accessed December 2014. Retrieved from: http://www.who.int/mediacentre/news/releases/2014/world-health-statistics-2014/en/.

[2] Human Mortality Database. Accessed December 2014. Retrieved from: http://www.mortality.org.

[3] United Nations, Department of Economic and Social Affairs, Population Division (2011). World Population Prospects: The 2010 Revision, CD-ROM Edition. Accessed December 2014. Retrieved from:  http://esa.un.org/wpp/.

[4] World Health Organization (2013). Draft Twelfth General Programme of Work. Accessed December 2014. Retrieved from: http://www.who.int/about/who_reform/programme_priority/en/.

[5] World Health Organization (2014). Ageing and Life Course. Accessed December 2014. Retrieved from: http://www.who.int/ageing/en/.

[6] United Nations, Department of Economic and Social Affairs, Population Division (2013). World Population Aging Report. Accessed December 2014. Retrieved from: http://www.un.org/en/development/desa/population/.

[7] The International Longevity Center Global Alliance (2010). Global Aging Report. Threats to Longevity. A Call to Action. Accessed December 2014. Retrieved from: http://www.ilc-alliance.org/index.php/reports/.

[8] Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. (2012). Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 380:2095-2128.

[9] Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. (2012). A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010, Lancet, 380:2224-2260.

[10] Kennedy BK, Berger SL, Brunet A, Campisi J, Cuervo AM, Epel ES, et al. (2014). Geroscience: linking aging to chronic disease. Cell, 59:709-713.

[11] Healthspan Campaign (2013). NIH Geroscience Interest Group (GSIG) Releases Recommendations from the October 2013 Advances in Geroscience Summit. Accessed December 2014. Retrieved from: http://healthspancampaign.org/2014/02/27/nih-geroscience-interest-group-gsig-releases-recommendations-october-2013-advances-geroscience-summit/

[12] Fahy GM, West MD, Coles LS, Harris SB (Eds). The Future of Aging: Pathways to Human Life Extension. New York: Springer; 2010.

[13] Fontana L, Kennedy BK, Longo VD, Seals D, Melov S (2014). Medical research: treat ageing. Nature, 511:405-407.

[14] López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G (2013). The hallmarks of aging. Cell, 153:1194-1217.

[15] De Grey ADNJ, Rae M. Ending Aging. The Rejuvenation Breakthroughs That Could Reverse Human Aging in Our Lifetime. New York: St. Martin’s Press; 2007.

[16] Goldman DP, Cutler D, Rowe JW, Michaud PC, Sullivan J, Peneva D, Olshansky SJ (2013). Substantial health and economic returns from delayed aging may warrant a new focus for medical research. Health Aff, 10:1698-1705.

[17] Rae MJ, Butler RN, Campisi J, de Grey ADNJ, Finch CE, Gough M, et al. (2010). The demographic and biomedical case for late-life interventions in aging. Sci Transl Med, 2:40cm21.

[18] Kanfi Y, Naiman S, Amir G, Peshti V, Zinman G, Nahum L, et al. (2012). The sirtuin SIRT6 regulates lifespan in male mice. Nature, 483:218-221.

[19] Atala A. Extending life using tissue and organ replacement (2008). Curr Aging Sci, 1:73-83.

[20] Baati T, Bourasset F, Gharbi N, Njim L, Abderrabba M, Kerkeni A, et al. (2012). The prolongation of the lifespan of rats by repeated oral administration of [60] fullerene. Biomaterials, 33:4936-4946.

[21] Kheir JN, Scharp LA, Borden MA, Swanson EJ, Loxley A, Reese JH, et al. (2012). Oxygen gas-filled microparticles provide intravenous oxygen delivery. Sci Transl Med, 4:140ra88.

[22] Shawn M. Douglas SM, Bachelet I, Church GM (2012). A logic-gated nanorobot for targeted transport of molecular payloads. Science, 335:831-834.

[23] Kennedy BK, Pennypacker JK (2014). Drugs that modulate aging: the promising yet difficult path ahead. Transl Res, 163:456-465.

[24] Chung HY, Cesari M, Anton S, Marzetti E, Giovannini S, Seo AY, et al. (2009). Molecular inflammation: Underpinnings of aging and age-related diseases. Ageing Res Rev, 8:18-30.

[25] Lunn JS, Sakowski SA, Hur J, Feldman EL (2011). Stem cell technology for neurodegenerative diseases. Ann Neurol, 70:353-361.

[26] Baylis D, Bartlett DB, Patel HP, Roberts HC (2014). Understanding how we age: insights into inflammaging. Longev Healthspan, 3:6.

[27] Dai DF, Chiao YA, Marcinek DJ, Szeto HH, Rabinovitch PS (2014). Mitochondrial oxidative stress in aging and healthspan. Longev Healthspan, 3:6.

[28] Zieman S, Kass D (2004). Advanced glycation end product cross-linking: Pathophysiologic role and therapeutic target in cardiovascular disease. Congest Heart Fail, 10:144-149.

[29]      Bredenkamp N, Nowell CS, Blackburn CC (2014). Regeneration of the aged thymus by a single transcription factor. Development, 141:1627-1637.

[30] This position paper of the International Society on Aging and Disease (ISOAD) was published on behalf of the ISOAD Executive Committee as: Kunlin Jin, James W. Simpkins, Xunming Ji, Miriam Leis, Ilia Stambler (2015). The critical need to promote research of aging and aging-related diseases to improve health and longevity of the elderly population. Aging Disease, 6(1):1-5

http://www.aginganddisease.org/EN/10.14336/AD.2014.1210

 

 

 

 

15 Мая 2015 года – 170-летие Ильи Ильича Мечникова – основателя геронтологии – возможность популяризировать исследования старения и долголетия

METCHNIKOFF FOR SITE15 Мая, 2015 является 170-й годовщиной со дня рождения основателя научных исследований старения и долголетия, автора термина «геронтология», нобелевского лауреата – Ильи Ильича Мечникова (15 Мая, 1845 – 15 Июля, 1916). Для сторонников здорового долголетия и исследований старения и продления жизни, годовщина дня рождения Мечникова имеет особое значение. Мечников – всемирно признанный ученый, сыгравший основопологающую роль в становлении ряда научных направлений – иммунологии и иммунотерапии, геронтологии и геронтотерапии –  является объединяющим культурым символом для многих исторически связанных народов.

Существует традиция праздновать дни рождения и юбилеи великих людей (ученых, художников, писателей, политиков, полководцев) для продвижения сфер их деятельности, для популяризации их идеологии. В этом году возникла международная инициатива отметить юбилей Мечникова, в надежде, что подобная акция послужит для продвижения и популяризации науки и идеологии продления здоровой жизни, вплоть до государственного уровня. «День Мечникова» может послужить толчком для организации тематических встреч и конференций, стимулом для исследований, и публикаций СМИ, посвященных наследию Мечникова и продолжению дела его жизни – изучению старения и долголетия, что может сыграть позитивную роль не только в содействии и пропаганде исследований старения и здорового долголетия, но и послужить укреплению духа оптимизма, делу мира и сотрудничества.

В настоящее время, мероприятия (встречи и публикации) в честь Дня Мечникова планируются в нескольких странах различными общественными и научными организациями, ратующими за развитие исследований старения и продления жизни, включая высокоавторитетные национальные ассоциации и научные центры.

Планируются встречи и семинары – в Киеве, Украина, от Киевского Института Геронтологии Национальной Академии Медицинских Наук Украины; в Санкт Петербурге, Россия – под эгидой Геронтологического Общества Российской Академии Наук и Северо-Западного Государственного Медицинского Университета имени И.И. Мечникова; в Москве под эгидой Федерального Центра Профилактической Медицины Министерства Здравоохранения Российской Федерации, встречи в Москве также планируются рядом общественных организаций, таких как Федоровское Движение, Российское Трансгуманистическое Движение и Российский Альянс за Продление Жизни. Также планируются семинары в Ларнаке, Кипр, от Фонда ЕЛПИ и Института Технологии и Нейронауки Кипра; в Оксфорде, Англия, под эгидой Научного Общества Университета Оксфорд и Фонда Биогеронтологических Исследований; в Рамат Гане, в Университете Бар Илан, Израиль, под эгидой Израильского Альянса за Продление Жизни и Международного Общества по изучению Старения и Болезней (Израильское отделение).

Можно надеяться, что, следуя этим примерам, будут организовываться дополнительные встречи и публикации для популяризации исследований старения и долголетия, приуроченные к этому дню или близлежащим.

До 15 мая остается совсем немного времени, возможно достаточно для подготовки небольшой публикации или встречи, личной или в сети. Но авторитет Мечникова может помочь нам поднять тему исследований старения и долголетия и в будущем году – 15 июля 2016 года исполняется 100 лет со дня смерти Мечникова. Это также может дать стимул встречам и публикациям, с большим временем для подготовки. Проведение мероприятий в различных странах в один день и в рамках международной акции может  произвести эффект взаимного усиления. Конечно, эти дни – не единственные, когда такой эффект возможен. Дополнительным удобным днем для проведения международной акции в поддержку исследований старения и долголетия может стать 1 Октября 2015 года – официально санкционированный ООН “Международный День Пожилого Человека” (также отмечается частью активистов за исследования старения и долголетия как “Международный День Долголетия”). События в честь этого дня в районе 1 Октября 2013-го и 2014-го года проводились различными группами активистов, общественными и научными организациями в десятках стран.

http://www.longevityforall.org/october-1-international-day-of-older-persons-longevity-day-2013-2014/

Надеемся, благодаря нашим совместным усилиям, «сверху» и «снизу», благодаря событиям, организованным в эти и другие дни —  необходимость содействовать исследованиям старения и возрастно-зависимых заболеваний для улучшения здоровья и долголетия пожилого населения будет признана всеми слоями общества, включая широкую общественность, профессиональное и научное сообщество, и руководство, и станет стимулом к действиям, соответствующим важности и срочности проблемы.

http://www.longevityforall.org/the-critical-need-to-promote-research-of-aging-around-the-world/

Надеемся на Вашу поддержку!

См. также более полное объявление односительно этого дня, включая описание основопологающей роли Мечникова в становлении исследований старения и долголетия и список организуемых мероприятий (список будет дополняться)

http://www.longevityforall.org/170th-anniversary-of-the-founder-of-gerontology-elie-metchnikoff-may-15-russian/

Копия этого объявления

http://www.longevityforall.org/may-15-2015-metchnikoff-day-russian/

И английская версия

http://www.longevityforall.org/may-15-2015-170th-anniversary-of-elie-metchnikoff-the-founder-of-gerontology-an-opportunity-to-promote-aging-and-longevity-research/

 

С уважением,

Др. Илья Стамблер. Координатор по общественным связям.
Международное Общество по Изучению Старения и Болезней
International Society on Aging and Disease (ISOAD)
Отделение Науки, Технологии и Общества. Университет Бар Илан. Израиль
ilia.stambler@gmail.com
972-3-961-4296
http://isoad.org/
http://www.longevityforall.org/
http://www.bioaging.org.il/
http://www.longevityhistory.com

 

October 1 – International Day of Older Persons – Longevity Day – 2013-2014

Logo Old withou archThere has been emerging a tradition by longevity researchers and activists around the world to organize events dedicated to promotion of longevity research on or around October 1 – the UN International Day of Older Persons. This day is sometimes referred to in some parts of the activists community as the “Longevity Day”, and the extended period of activity coinciding with it as “Longevity Week” or even “Longevity Month”. This symbolic day and period can be a great opportunity to raise the topic of longevity research in the mainstream.

In 2013, events during or around that day and period – ranging from small meetings of friends to seminars and rather large conferences, alongside publications, distributions of outreach materials (petitions and flyers) and media appearances – were held in over 30 countries, and in 2014 in over 2o countries.

Some reports and pictures coming from around the world can also be found here:  https://www.facebook.com/LongevityDay

Some events were purposely planned to coincide with the International Day of Older Persons, some just coincided. Often the events were organized by quite unrelated organizations. Also, some events included in the lists below took place at some time from October 1, to indicate not just a “Longevity Day” but an entire “Longevity Month”.

Yet, they all emphasize the tremendous importance of research and development in Biology of Aging and Longevity for the health, well-being and longevity of older persons.

Please join these research and advocacy efforts by organizing, supporting, promoting or participating in educational events or conferences dedicated to biology of aging and longevity in your area! This is valid not just for the month of October, but for the entire year!

By our joint efforts, we can contribute that biology of aging and longevity shall become one of the main (if not the main) topics on the scientific and healthcare agenda – the place this topic deserves and requires!

Below is the report about the celebrations of events to promote longevity research on or around October 1, the International Day of Older Persons, that took place back in 2013, and following it in 2014. Hopefully, similar or better events will take place in the years to come!

“In 2013 The world’s first International Longevity Day took place on or around October 1 (the UN International Day of Older Persons), in over 30 countries! http://www.longevityday.org/ These were many small steps on the great road to healthy longevity for all through support of longevity research!

1. Belgium

A large press conference took place, were three experts spoke to journalists (representatives of the French-speaking press):

  • Laurent Alexandre, physician, creator of the medical website Doctissimo, author of the book “La mort de la mort. Comment la technomédecine va bouleverser l’humanité” (The death of death. Technomedicine and how it will change humanity).
  • Didier Coeurnelle, co-chair of Heales (http://www.heales.org), author of the book “Et si on arrêtait de vieillir ! Réalité, enjeux et perspectives d’une vie en bonne santé beaucoup plus longue” (“What if we stopped aging: Reality, challenges and prospects for much longer and healthier life).
  • Miroslav Radman, cellular biologist, member of the French Academy of Sciences, author of the book “Au-delà de nos limites biologiques” (Beyond our biological limitations).

The amount of press and exposure to longevity from this event was great! At least 10 journalists were present from Belga, the RTBF, RTL, La Libre Belgique, Le Vif l’Express and other smaller media. Some media reports online: LevifRTLLesoir Pictures of the press conference.  Slightly earlier, an pro-longevity public relations action was conducted by the European Healthy Life Extension Society – Heales – at the Night of Researchers gathering on September 27 inBrussels. Thanks Martine Verhaeghe de Naeyer for this great work, especially the contacts with the journalists. Thx Guy Weets for filming. Thanks to Frederik Cheeseman for the pictures. Thanks Alexander Tietz and Victor Bjork for being there ready to help Thanks to all who made this possible! 

2. Netherlands

A small circle meeting was organized by Amanda Stoel in Bussum, Netherlands. The meeting included a discussion about how realistic longevity was, about google now taking on anti-ageing and about specific holistic ways to promote health and longevity. http://wellnesscoachamanda.tumblr.com/https://www.facebook…ty.Netherlands/.

3. Ireland

Martin O’Dea and Brian Collins report: On International Longevity Day Eve, the Irish group ‘Combat Degenerative Ageing’ held its inaugural meeting in Dublin. There were 6 attendees, though 3 others, to whom we must apologise profusely, turned up only to miss us due to our organisational teething issues!! Sorry guys! The meeting was very engaging and a presentation was visited through the event which ran from a supposed one hour and a half to much longer. The level of interest evident in the issues of longevity research and advocacy again indicative of what so many know – that when openly and honestly discussed this is just the most interesting field for interest and involvement for people with all different backgrounds, and is ultimately about us all. We look forward to holding monthly meetings and developing the organisation in other ways and in conjunction with the ever growing number of similar efforts around the world.

4. Australia

A meeting for Longevity Day was organized by Adam Ford in Melbourne, Australia. As the original announcement eloquently put it: “Lets celebrate the impetus for research and development into mitigating the harmful effects of aging, increasing the likelihood of a world free of age-related disease! Now you know you should be coming for a fascinating discussion on recent developments in R&D into longevity/rejuvenation research.  Can you dig it?” Adam Ford reports: “We had about 20 people turn up. … There were a lot of great discussions.” Also in honor of the International Longevity Day and the almost concurrent Google’s Anti-Aging initiative (announced on September 18 and appearing on the cover of Time magazine on September 30), interviews were conducted by Adam Ford with stalwarts of the worldwide longevity movement: Ben GoertzelAubrey de GreyChristine PetersonKarl HaleJames HughesAnders Sandberg: See also the group https://www.facebook…ianceAustralia/  

5. Israel

On October 1, the International Day of Older Persons/ International Longevity Day, the conference took place in Tel Aviv, at the Hemda Science Education Center, titled “From Biology of Aging to Longevity and Quality of Life”. The conference was a success! Over 70 researchers and research students participated, from all the universities in Israel, with 16 presentations by some of the top researchers. Over 30 submissions were made for the excellence prize for the research of biology of aging, longevity and quality of life, and 8 prizes were awarded to 8 applicants from 8 different laboratories! Many thanks to Dr. Eitan Krein, director of the Science program at Hemda Science Education Center in Tel Aviv and Yanki Margalit, the social entrepreneur and Chairman of SpaceIL Foundation – for making this event possible! Many thanks to the judges of the excellence prize: Prof. Vera Gorbunova (US), Prof. Zipora Yablonka-Reuveni (US), and Prof Gil Atzmon (US). Here is the conference program,  Video-recordings of the conference presentations and some pictures. In addition, over 150 people attended the session for the general public that was held after the conference. Special thanks to Dr. Yaakov Ben Shaul for helping to spread the word about the conference and the subject of longevity research in the Israeli mass media on that day, including several tv, radio and newspapers interviews! Many thanks to all the wonderful people who attended, contributed proposals and presentations, helped and supported! Hopefully, many more activities in support of longevity research will follow – raising public awareness and lobbying for the field of the biology of aging and longevity research and its importance for the public health in Israel and everywhere!

6. India

Two seminars on longevity research were organized in India by members of India Future Society http://indiafuturesociety.org/ One was organized by Siddartha S Verma in Bangalore.  As Siddartha reports: The event started with 6 to 7 people in Bangalore. In the first session, a video talk on “Google vs. Death- Google’s and other Anti-Aging Initiatives” by Ben Goertzel  was shown to the audience. Then, a video talk on “Google Vs. Death: an Anti-Aging initiative- Progress in regenerative medicine” by Aubrey de Grey was shown. A half an hour break was provided to the audience for lunch, in which Italian Pizzas were offered for free to them. Following that, there was a talk on “Longevity Day” for 30 minutes (by Siddartha). Audience were then engaged in a Game Round for 45 minutes, in which a list of Longevity related questions were asked to them. An interesting set of answer was obtained. Each of these rounds were followed by a Question and Answer session. Penultimate session was a 30 minutes TED talk by Aubrey de Grey on- “Anti-aging research and Biology”.  Last session was a closing and feedback session for all the people. Some pictures from the meeting.

Another longevity day event was organized in Uttar Pradesh by Avinash Kumar Singh of the India Future Society

As Avinash reports: The Longevity Day event/open discussion was conducted at Harcourt Butler Technological Institute Kanpur on 1st October, 2013. The target audience of this event were Professors and Researchers. The Agenda of the discussion was: 1. What is Longevity ? 2. Why is it needed ? 3. What are the possible ways of Longevity ? The main speaker of the event was Mr Rahul Singh, who is a researcher in the Vedic Sciences. He explained about possible longevity ways, trends and reasons behind the death. In the open discussion most of the people agreed and concluded that Digital Immortality is the only possible way. People also believe that Indian Vedic Science already has several ways to achieve longevity. One of the most common ways is the Kundalini Energy Control or in other words advanced level of Yoga to achieve Longevity. At the end of Open Discussion, We’ve shown a movie “Transhuman” of about 30 min focused on Digital Immortality. Some pictures from the meeting.

7. Pakistan

Two meetings for longevity day were organized in Pakistan by members of Longevity Pakistan group. One was organized at the Department of Zoology, University of Peshawar, Pakistan, by Wisal Khan. As Wisal reports, about 70 people participated including advanced students (MSC, MPhil, and PhD) and about 10 Faculty members. A presentation was shown about the basic concepts of Transhumanism and Life extension An additional event was organized by Prof. Muhammad Aslamkhan at the University of Health Sciences, Lahore, Pakistan, where about 30 people participated. The paper was read by Prof. Aslamkhan entitled “Longevity: Add Years to Your Life – But How?”

8. Russia

Longevity Day in Moscow. Elena Milova reports: The Russian Transhumanist Movement – RTM (http://transhuman.ru/) and the Culture Center “NEGA” jointly conducted the celebration of the International Longevity Day on October 5, 2013, aligning with the International Day of Older Persons. The speakers were the futurologist Danila Medvedev and gerontologist Igor Artyuhov. They convincingly told the audience about the latest achievements of medicine allowing us to hope for a radical extension of longevity, already in the next 20-30 years. There was an encouraging wave of questions and a short discussion dedicated to problems of implementing the already existing technologies. Among other topics, there was discussed the necessity to recognize aging as a disease. Such a recognition should introduce into practice the prevention of degenerative aging, which, among other benefits, would simplify the procedures for registration and massive application of geroprotective substances. The complete video-recording of the meeting And photographs,  including photographs from the NEGA website. During the meeting, there were shown video greetings from supporters of life extension from other countries, representatives of the International Longevity Alliance (ILA): Ilia Stambler, the longevity scientist and activist from Israel (in Russian and English) and a team of longevity scientists and activists from Ukraine: Anton Kulaga, Dmitry Shytikov, and others (in Russian and English). Information and advice regarding the prevention of the aging process by the already known methods were presented by representatives of the Russian Transhumanist movement. These were accepted with gratitude and interest. Later, in the lobby, interested persons could buy the book by Aubrey de Grey – “Ending Aging” in Russian and the book by Mikhail Batin “Cures against Aging”. After the event, the participants had hot beverages and simple refreshments, and networked with speakers and activists of the Russian Transhumanist Movement in an informal atmosphere. Three days after this event, on October 9, 2013, the Culture Center NEGA hosted the meeting of the RTM speaker Elena Milova and the young scientist Yury Matveev with the club of WWII veterans – “My Dear Friend”. The supporters of radical life extension told the veterans about the activity of the RTM in the field of science popularization, and the key task – the delay and reversal of aging thanks to advances of the Scientific and Technological Progress. Despite the advanced age of the majority of the meeting participants, they actively participated in the discussion, asked questions, commented on the situation with healthcare and expressed ideas on what they can do to help science. In addition, the Longevity Day initiative was supported by the Russian Science for Life Extension Foundation (http://www.scienceagainstaging.org/) and the Fedorov’s movement (http://nffedorov.ru/)

9. Ukraine

In Kiev, Ukraine, the International Longevity Day was celebrated at the Institute o Gerontology of the Ukrainian Academy of Sciences (Kiev, Vyshgorodsky St. 67), in the main conference hall. The presentations included – Foreword by the organizing committee; a video-greeting to the conference participants from several countries: FranceIsraelVenezuela Lectures were presented by Anton Kulaga (International Longevity Alliance) on International activism for life prolongation, Dmitry Shytikov (Laboratory of immunology and pathophysiology of the Kiev Gerontology Institute) – Crowdfunding as a method of financing lifespan extension experiments – practical experience, Alexander Kolyada (Laboratory of Epigenetics of the Kiev Gerontology Institute) – genetics and epigenetics of aging, and Volodymir Semenyuk– The role of citizen science in the combat of aging. At the time of the Longevity Day, a pioneering initiative was being conducted by the Ukrainian longevity activists and scientists, in cooperation with international activists – the crowdfunding effort to fund lifespan extension experiments in mice: http://www.indiegogo…-to-live-longer The crowd-funding campaign was a success! As the organizers, Anton Kulaga, Edouard Debonneuil, Irina Pishel, Dmitry Shytikov, and Daniel Wuttke report: Little mouse crowdfunding campaign – mission accomplished! So now it is time for hard work on experiments and producing valuable results. Thank you so much for making this possible!http://www.indiegogo…nger?c=activity

10. France 

A Longevity Day meeting was organized in Sceaux, close to Paris, France, by Edouard Debonneuil, head of the Longévité & Santé (Longevity and Health) Association. The meeting took place on Saturday afternoon, October 5th. This interactive conference included presentations by prominent researchers of the biology of aging, such as Fathi Moussa, who presented on his work on “Fullerens and Longevity”.

The meeting also included such activities as a longevity quiz to introduce advances in longevity,  both in terms of science and socio-economics.
– A strong emphasis on health was developed by David Latapie: what the future could look like depending on choices made today, how to educate citizens and inform decision-makers about the importance of biomedical prevention of aging as a key priority among health priorities.
– The interesting presence of top experts in the audience led to intense, constructive and interesting debates. – A panel of suggestions by the audience on how to add more years of healthy life was built, ranging from promoting better lifestyles and preventing falls to fostering research on aging and testing long term effects of medicines, chemicals and interventions. Also, “Trust Science” was the consensual message to decision-makers willing to truly increase healthy life.
Finally, the participants went to a restaurant to meet and know each other. Here are some pictures from the meeting.
Special thanks to Edouard for creating the main site for the Longevity Day http://www.longevityday.org/
And for promoting this event worldwide.
11. Germany 

On October 1, a discussion group about Longevity Research was organized at the University of Bremen, Germany, by Hashem Al-ghaili. In addition Hashem published a promotional appeal about the Longevity Day via his extensive social network (over 25,000 followers). Hoping for more field activity and online presence for longevity in Germany! The same can be said for Austria, where efforts to organize meetings and create website presence have been made in Vienna. 

12. The UK

Several events took place in the UK in conjunction with the Longevity Day. On September 29, the eve of the Longevity Day, David Wood, head of London Futurists, organized a public broadcast on Projects to accelerate radical healthy longevity the London Futurists hangout with Franco Cortese Ilia Stambler, Maria Konovalenko and Aubrey de Grey. The exploration started with a meetup, held as a Google “Hangout On Air” and broadcast live on YouTube, in which four panellists shared news and views on: • Projects they (or their organisations) have recently completed • Projects they are working on and/or planning to do next • Any issues that are blocking them from doing more. The panellists also discussed ways in which a wider community of people can usefully become involved in activities to accelerate radical healthy longevity. http://hplusmagazine…aubrey-de-grey/ Here is the complete video-recording Complete project description. – An additional meeting was held at Queen’s Larder, in London, by members of the Zero State group, on September 28: According to the organizer, Amon Kalkin: One of the most energetic areas associated with Futurism, Transhumanism, & Singularitarianism is that of longevity research and advocacy. While Zero State has not run any kind of longevity research or advocacy project up until this point, we intend to set up a group to explore the possibility of supporting longevity activism led by other organizations, with particular emphasis upon those which are affiliated with the broader Wave movement for positive social change through technology (of which ZS is a part). In short, Zero State is evolving to become part of something larger and even more exciting, and that process is marked by a new engagement with longevity activism. We’re very excited about this, and hope to become a significant part of the movement to defeat ageing over the next few years, particularly through vigorous support of other organizations. Please read the full report about this meeting here: http://wavism.wordpr…eeting-summary/ Or here: http://www.longevity…ed-kingdom.html

In addition, the Longevity Day was endorsed by several UK life-extensionist organizations, such as:

Longevity Intelligence Communications (LIC), recently started by Stuart Calimport, promoting collective actions and public affairs for longevity http://lonintelcomms.tumblr.com/ Longevity Intelligence Communications also promoted a petition in support of the Longevity Day https://secure.avaaz…_Older_Persons/

The leader of the British Longevity Society, Marios Kyriazis, also expressed his support. A major action of the society is planned for October 29, when the society will organize a meeting with the Minister for Care and Support Mr Norman Lamb, at the House of Commons. Also, support for the Longevity Day was expressed by several prominent members of the Methuselah Foundation and SENS research foundation, also during the recent SENS6 conference, earlier in September in Cambridge http://www.sens.org/…nferences/sens6. Most prominently by Aubrey de Grey.

13. The US

On October 1, there was a special meeting titled “Hacking Health: Dr Sean Mooney on how computer geeks are fixing our biology” at  Health ExtensionSalon, in San Francisco, California. As well said by the organizer, Joe Betts Lacroix: “Most biologists are now underqualified to interpret massive genetic data, so we need to bring in the tech community to save our lives. Dr. Sean Mooney, the director of the Bioinformatics Department at the Buck Institute on Aging, described how people with computer skills are making the next wave of discoveries relating to our biology, and in particular, how we can learn to prevent age-related diseases by mining the data in our genomes. Soon, that data will multiply by orders of magnitude, as DNA sequencing goes clinical. Celebrate INTERNATIONAL LONGEVITY DAY! = Oct 1st

In addition, the Longevity Day was endorsed by many life-extensionist organizations in the US, including:

Longecity, whose director Justin Loew also endorsed this day on TV. http://www.longecity…y-on-october-1/ Fight Aginghttps://www.fightagi…ngevity-day.php IEET – Institute for Ethics and Emerging Tecnnologieshttp://ieet.org/inde…IEET/print/8217 Humanity Plus Magazinehttp://hplusmagazine…aubrey-de-grey/ Immortal Life http://immortallife….ow-your-support Which slightly earlier held a large conference in support of Longevity research in Washington DC, on September 22. Brighter Brainshttp://brighterbrain…l-longevity-day

And several others.

14. Egypt

A ground-breaking effort to promote Longevity Advocacy was made in Egypt, led by Ahmed Adel Ibrahim. Some of the activities included building probably the first of its kind pro-longevity websites in Arabic, including: Egypt Plus http://www.egyptplus.org/ Longevity Egypt  http://longevityegypt.wordpress.com/ and Egyptian Cryonics Societyhttp://egyptiancryon….wordpress.com/ And initiating a longevity interest group: Longevity Egypt – الرابطة المصرية لإطالة الحياة https://www.facebook…LongevityEgypt/ A strong effort was made to organize a meeting in support of longevity research for Longevity Day in Cairo. Even though it was not possible to conduct such a meeting, these pioneering efforts will grow inexorably. Additional efforts to organize groups and meetings have been made in Iraq, and Iran (Tehran specifically). Though, in these cases too, it was not yet possible to organize meetings. Yet, there is very little doubt that pro-longevity events will take place there rather sooner than later! To encourage such activities and information outreach in the Middle-Eastern languages (Arabic, Persian, Hebrew, Turkish, Kurdish, Urdu, and others), a new site is currently under construction: Longevity Middle  East www.longevitymideast.orghttps://www.facebook…vityMiddleEast/ Contributions are welcome!

15. Spain

For the longevity day, a meeting took place in Seville, Spain, of a working/initiative group of prominent Spanish and Portuguese transhumanists, including:  Sergio Tarrero and Javier Ruiz (from Spain) and José Raeiro and Mafalda Dias (from Portugal) and others. More news will be soon forthcoming from Spain! Stay tuned!

Several events in support of longevity research were organized in several Latin American countries toward the International Longevity Day. These events are path-setting!

16. Venezuela

On October 1, a conference took place at Jose Antonio PaezUniversity San Diego, Carabobo, Venezuela Titled “The Longevity Day: Overcoming the Biological Barriers” According to the organizer, Abelardo Jesus Marquez ofLongevity Venezuela: There were made presentations made by Edison Alexander Duran, explaining the way to transhumanism and radical life extension thanks to the latest developments in science and technology, and by Abelardo Jesus Marquez talking about the latest developments in robotics and how these will help us improve the human. A strong support for the Longevity Day was given by the prominent Venezuelan futurist Jose Cordeiro, who recorded an inspiring video greetingfor that day that was distributed from Peru to Ukraine, and who also promoted the idea of Celebrating the Longevity Day during his travels in East Asia during this period: in North and South Korea and China. As Abelardo Marquez reports: The feedback after the event was really positive, many of the attendees commented to us that they had no idea of the current state on scientific developments towards longevity and that they would from now on, try to know more about it. Please read the full report and see some pictures from the meeting here: http://www.longevity…/venezuela.html

17. Mexico

A meeting was being organized by a small group of Mexican longevity activists in Mexico City. Hoping for increased activity.http://www.longevity…org/mexico.html http://100ciaysalud.blogspot.mx

18. Brazil

Efforts were being made to organize meetings in Brazil: in São Paulo and Santa Maria. Yet, eventually it was not possible to conduct the meetings. Nonetheless, the Longevity Day was promoted in the widely read media outlet by Andre Massaro from São Paulo. This was probably one of the premier pieces of advocacy for longevity research in Brazil! Every little bit of action and information counts! http://exame.abril.c…da-longevidade/

19. Argentina

A screening of a video by Aubrey de Grey was done by a group oflongevity supporters in Mar de Ajo in Buenos Aires area, organized by Sebastian Andres Presta. Hoping for more actions!

20. Colombia

Yet, the strongest activity for Longevity Day in Latin America was conducted by the Colombian Longevity Alliance, led by Adrian Correa. Also special thanks to Julio Andres Acosta for his support! Toward the International Longevity Day, the Colombian group took on itself the creation of the logo for the International Longevity Alliance, as well as the creation of most of the promotional materials (flyers and posters). A radio interview was conducted in honor of that day by Adrian Correa as well as several promotional recordings on youtube.

But the main achievement was the creation of the site for the promotion of different branches of longevity research in Spanish!

http://alianzalongevidad.com/

Thanks Adrian Correa!  This site is hoped to help increase the global awareness and involvement of speakers of Spanish – the second most spoken language in the world – with almost 400 Million speakers. Yet, information about Longevity Research and Advocacy is extremely scarce in Spanish. This will be probably one of the first sites (if not the first) dedicated specifically to the topic. This is a ground-breaking development. Hopefully, there will be more sites created to promote longevity research and advocacy in various national languages, in which information is scarce. There is little information in such languages as German, French and Italian. And it is extremely scarce for languages of Eastern Europe, Middle East, Africa and Asia! We must help to replenish this scarcity!

21. Italy.

Toward the International Longevity Day, there was an activation of the Italian group of the International Longevity Alliance (Longevisti  http://longevisti.it/) According to the activists Massimiliano Maidano, David de Biassi, and Sergio Bossi, A group of 6 people met in Turin, Italy, for a discussion of longevity science during the Longevity Day – Oct. 1. Apparently this is the first group of Italian longevity activists to meet in a physical setting. As members of the Italian Longevity Alliance are scattered across Italy and even other countries, a skype meeting of the most active members was conducted on that day. The main conclusion was to encourage the creation of other “offline” local groups of activists in other cities, on the example of Turin. In addition, the Italian group (especially Massimiliano Maidano and David de Biassi) was instrumental in developing the concept of the International Longevity Alliance logo (that was finalized toward the Longevity Day) and the development of the Longevity Art group https://www.facebook…s/LongevityArt/. Furthermore, the site of the Italian branch of the Longevity Alliance was elaborated and expanded – increasing the amount of information and outreach in Italian. http://longevisti.it/

22. Serbia

A radio program about anti-aging research was organized in Belgrade by Dragan Tabakovic (Longevity Serbia group).

23. Romania

A study session on anti-aging and longevity research was organized in Constanta, Romania, by Alexandru Chircu. According to Alexandru: We’ve talked about the importance of delaying aging, about it’s ethics, then we presented a list of substances that help us stay young (mostly racetams). There was not enough interest from the participants for a study group, but we hope to have better luck next year. See the emerging groups of Romanian longevity activists: Longevity Constanta and Longevity Party Romania

24. Czech Republic

Toward the Longevity Day, the Czech longevity activism group was created. According to the founder, Gunther Kletechka “The group was created and several people joined. There was no too much activity in the group other that occasional posting. The most significant was that the group was created.”

25.Slovakia

Also the Slovak longevity activism group was created toward the Longevity Day. The group that will work in tight cooperation with the Czech and Austrian group. Thanks Nicola Gigante for your initiative! Looking forward to more activism. 26.Bulgaria And yet another Easter European longevity activism group was established by Lilia Lens-Pechakova, originally from Bulgaria. This group is called “Closing the East-West Gap” and is dedicated to bring the level of longevity and longevity research in countries of Eastern Europe to that of Western Europe – and both to an ever higher level! Closing the East-West Gap group: https://www.facebook…theeastwestgap/ Longevity Bulgaria Group: https://www.facebook.com/groups/HLEBg/

27. Poland

On 26-27 September 2013, during 1st International Interdisciplinary Conference on CHALLENGES IN LANGUAGE and in Conjunction with the International Longevity Day, there was held  a conference at Instytut Języków Obcych PWSZ w Nowym Sączu (at the General Philological Institute at Nowy Sacz, Poland). Dr. Monika Madej-Cetnarowska organized a special session at the conference about the legacy of Nikolay Fedorov, suggesting Longevity and the Fight with Death as the common unifying task of humanity. 3 papers were presented on this subject. Group: http://www.facebook….ityPartyPoland/

28.Finland

On October 1, a meeting was held in Helsinki According to Antti Peltonen, Ville Salmensuu, and Teo Piitulainen: There was 3 of us. There was Ville’s report in Longevity Finland facebook group (but in Finnish). Which went pretty much like: “We were gathered by the invitation of Antti, to discuss about how longevity could work in Finland. We decided to establish a web community (compare LessWrong, Stack Overflow, Slashdot), where we could share practical and reliable information about long and healthy life, in Finnish and for Finns. Still looking for a good name for it. The whole thing would aim to healthy lives. We would meet up again after couple of weeks to check progress and discuss more. Probably in conjunction with LessWrong meeting. We have to see how it starts to progress from this onward. See the group “Longevity Finland” See also the emerging site of Longevity Finlandhttp://longevity.fi/  Photo from the meeting.

29. Benin

Serious effort was made to organize meetings in BeninWest Africa, that must be mentioned, as well as in Uganda, East Africa,  and in South Africa and Zimbabwe, and in Africa Generally https://www.facebook…ongevityAfrica/Let us hope – the level and scope of Longevity Activism and research in Africa will increase, as soon as possible!

30. Canada

The group of the Canadian Longevity Alliance has been established in this period, led by Franco Cortese. As Franco Cortese reports: The CLA will focus on representing the mission and vision of the ILA, and their policy and law-change initiatives, on the Canadian front. A shorter-term focus will be forming a network of Canadian activists, providing activists with free resources (like printable signs, petitions and informative literature to distribute to interested onlookers) to help reduce the logistical challenges facing activists and demonstration-organizers in organizing and implementing an activism demonstration, encouraging activists to become advocates on behalf of the CLA at speaking engagements and events, encouraging activists to directly participate in education and outreach initiatives, and organizing effective and actionable activist demonstrations in Canadian locales. Please read the full report here: http://longevityalli…evity-alliance/ Please visit the group: https://www.facebook…ongevityCanada/

31. Georgia

On the initiative of the longevity researcher and activist, Dr. Jaba Tkemaladze, on October 1, a petition was presented to the Head of State of the Republic of Georgia, Prime Minister Bidzina Ivanishvili, requesting to include in the budget for 2014 the financing for a small group of experts under the jurisdiction of the Ministry of Health and Social Insurance. The tasks of this group would be: 1) Search for ways and implementation of methods for complete elimination of disability. 2) Search for ways and implementation of methods to produce organs from the patients own cells, rather than transplantation from the donor. 3) Search for ways and implementation of methods for increasing the age of working capacity of the people. To realize these tasks, the petitioners requested the state to finance the work of a group of experts consisting of 3 people.

Similar legislative initiatives in support of longevity research, can and should be replicated around the world! http://longevityalli…rent-countries/

See the group of the Georgian longevity activists: https://www.facebook…ityPartyGeorgia And the page: https://www.facebook…ityPartyGeorgia

32. Japan

A meeting was being organized in Tokyo by John Leonard of Japan Longevity Alliance. See the Japan Longevity Alliance Website: http://www.japanlong…projectsevents/ And the group: http://www.facebook….ongevity.Japan/

Yet, generally, the participation in the Longevity Day from the emerging groups of the International Longevity Alliance in East Asia was limited. A certain disconnection is felt. Hopefully more cooperative events will be take place during the next concerted actions!

This equally relates to the emerging groups in Asia: China https://www.facebook…vityPartyChina/ Taiwán https://www.facebook…ityPartyTaiwan/

Korea https://www.facebook…53668691441017/ Thailand https://www.facebook…60726163937652/

Philippines https://www.facebook…rtyPhilippines/ Indonesia https://www.facebook…99662436778941/

Vietnam https://www.facebook…76090562663541/ and Singapore  https://www.facebook…PartySingapore/

33. Turkey

A group of international longevity activists – Daria Khaltourina, Didier Cournelle and Ilia Stambler – gathered in Istanbul, Turkey, at the International Initiative on Aging for Eastern Europe, Middle East and North Africa (October 4-7). Together they helped to introduce the topic of longevity research at 3 panels at the Conference – “Human Rights”, “The Pursuit of Longevity” and “Social Perspective of Ageing” and will endeavor to promote the longevity research and advocacy agenda further.

Moreover, a petition was presented to the UN to officially institute the celebrations of the Longevity Day, on October 1 or some other day.

An online version of the petition can be found and signed here: https://secure.avaaz…_Older_Persons/

Looking forward to more and stronger concerted actions in support of longevity research and for improving healthy longevity for all around the world!

And here are some events and conferences that were conducted on or around the Longevity Day – October 1, 2014 – in different countries and by various organizations. Looking forward to more!

  • Belgium. Brussels. Eurosymposium on Healthy Aging. Belgium. October 1-3. (Link) Report (Link) Recordings (Link/HealesMovies ;   Playlist)
  • The US. New York, USA – Cold Spring Harbor Laboratory meeting on Aging – “Molecular Genetics of Aging”. September 29-October 3. (Link) 
  • Beginning of SENS Research Foundation/Fight Aging Fundraising Campaign. October 1. (Link) 
  • New York. Longecity Chapter Meeting. October 1. (Link) 
  • Russia. Moscow.  LightSpan Action. October 1 (Link1; Link2) Recordings of people’s appeals (Link)
  • Russia. Moscow. Conference – Older Patient. Quality of Life – October 6-7 (Link) 
  • Israel. Bar Ilan University. Longevity Research and Its Social and Policy Implications. October 1 (Link1; Link2) Publication of the book: A History of Life-extensionism in the Twentieth Century (LinkLink)
  • Canada. Huntington University.  Canadian Institute for Studies in Aging (CISA). Seminar on muscle wasting and oxidative damage in aging. October 1 (Link) 
  • Canada. Mount Saint Vincent University. Canadian Association of Retired Persons (CARP). Longevity: The Road to a Longer Life. October 15. (Link) Recording (Link)
  • Spain. Oropesa. Biology of Human Aging. September 19-22 (Link1Link2)
  • Spain. Seville. Pablo de Olavide University. 9th European Congress on Biogerontology (ECB). October 16-18  http://upo.es/9ECB/
  • The  UK. London. London Futurists Meetup. The new future of old age. September 27. http://www.meetup.co…ents/201867002/
  • The UK. London. Alzheimer‘s Disease: An Overview. October 1-2 http://www.globaleve…se-an-overview/
  • The UK. London. 11th Anti-aging Conference. October 9-11 http://www.antiageingconference.com/
  • Germany. Frankfurt am Main. Goethe University. Fondazione IBSA for scientific researchAging. Is it a Disease? September 27 (Link)
  • Morocco. El Jadida. Replication as a Source of DNA Damage – From Molecules to Human Health. September 30-October 3 (Link) 
  • Cyprus. Larnaka. Stegi and Kyriazis Medical  Museum. Presentations addressing general health problems affecting older people. October 1. (Link)
  • India. Bangalore. Meeting of India Future Society. October 5. (Link 1Link 2). The videoconference recording (Link)  Special publication in honor of the Longevity Day at “DNA India” http://www.dnaindia….esearch-2025654
  • Pakistan. Lahore. October 1. Special Appeal in Honor of the International Day of Older Person on behalf of the Pakistan National Academy of Young Scientists (NAYS) (Link)
  • Brazil. Sao Paulo. Publication “On Challenges of Longevity” (Link)
  • Colombia. Bogota. “No Death” Action (Link)
  • Bulgaria. Sofia. Online meeting of activists of “Closing the East-West Gap” (Link)
  • Sweden. Stockholm. Meeting of the Swedish Life Extension Society. October 1. Launch of the Society’s new website (http://www.slfs.se/upprop/)
  • Finland. Helsinki. Meeting of Longevity Finland activists. October 1 (Link 1;  Link 2) 
  • Belarus. Gomel. Institute of Radiobiology of the National Academy of Sciences of Belarus. Gerontological aspects of anthropogenic factors. September 25-26. (Link) 
  • Switzerland. Basel. International symposium on geroprotectors: Practical Applications of Aging Research for Drug Discovery. September 23-25. (Link 1; Link 2)
  • Netherlands. Amersfoort. Permanent Beta. The Future of Life Extension. October 15. (Link)
  • China. Beijing. International Conference on Aging and Disease. The International Society on Aging and Disease (ISOAD). November 1-2   (Link) Conference Resolution: The Need to Promote Research of Aging and Aging-related Diseases as a Way to Improve Health of the Global Elderly Population (Link) – can be considered as the common conclusion and message of the “Longevity Month” of October 2014.

Die dringende Notwendigkeit zur Förderung der Erforschung des Alterns

Logo Detrans

Die dringende Notwendigkeit zur Förderung der Erforschung des Alterns und altersbedingter Krankheiten zur Verbesserung der Gesundheit und Lebenserwartung der älteren Bevölkerung

Kunlin Jin1,2, James W. Simpkins1,3, Xunming Ki1,4, Miriam Leis1,5, Ilia Stambler1,6

1Executive Committee, International Society on Aging and Disease (ISOAD), Fort Worth, TX76137, USA
2Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth, TX76137, USA.
3Center for Basic and Translational Stroke Research, West Virginia University, West Virginia, USA.
4Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China.
5FraunhoferGesellschaft zur Förderung der angewandten Forschung e. V. , München, Deutschland.
6Department of Science, Technology and Society, Bar Ilan University, Ramat Gan, Israel.

Übersetzung:    Marcel Mayr, Miriam Leis

Zusammenfassung: Durch die weltweite Alterung der Bevölkerung und der damit einhergehenden Zunahme altersbedingter, nicht- übertragbarer Krankheiten und der daraus resultierenden wirtschaftlichen Belastung, besteht der dringende Bedarf, die Erforschung des Alterns und altersbedingter Krankheiten zu fördern, um die gesunde und produktive Langlebigkeit für die alternde Bevölkerung zu verbessern. Um dieses Ziel zu erreichen, setzen wir uns für folgende Empfehlungen ein: 1) Erhöhung der Mittel für Forschung und Entwicklung mit dem konkreten Ziel, degenerative Alterungsprozesse zu mindern und die gesunde und produktive Lebensspanne der Bevölkerung zu erhöhen; 2) Die Schaffung von Anreizen  für kommerzielle, akademische, öffentliche und staatliche Organisationen, sich diesen Forschungs- und Entwicklungszielen zu widmen; und 3) Eine Förderung für den Aufbau und den Ausbau von koordinierenden und beratenden Strukturen, Programmen und Institutionen, die sich mit Altersforschung und damit verbundener Entwicklung und Ausbildung in Wissenschaft, Industrie und öffentlichen Einrichtungen auf nationaler und supra-nationaler Ebener befassen.


Schlagworte
: Altern, altersbedingte Krankheit, Gesundheit, Langlebigkeit, Senioren, Bevölkerung

Original: http://www.aginganddisease.org/EN/10.14336/AD.2014.1210

 

Die Herausforderung der alternden Gesellschaft und mögliche Lösungen

In den letzten Jahrzehnten hat sich die durchschnittliche Lebenserwartung weltweit erhöht und lag im Jahr 2014 global bei durchschnittlich 70 Jahren (6 Jahre höher als im Jahr 1990). In  technisch und wirtschaftlich hoch entwickelten Ländern liegt sie sogar bei ca. 80 Jahren (verglichen mit ca. 50 Jahren im frühen 20. Jahrhundert.)

Die Ursachen für diese Entwicklung beruhen v.a. auf verbesserter Hygiene, medizinischem Fortschritt, höherem Lebensstandard und dem Rückgang der Kindersterblichkeit. Während derzeit die höchsten Lebenserwartungen in technisch und wirtschaftlich hoch entwickelten Ländern zu verzeichnen sind, ist die Alterungsrate in Schwellen- und Entwicklungsländern besonders hoch. In Anbetracht der globalen demographischen Entwicklung wird sich der Anteil der über 60-jährigen im Zeitraum von 2000 bis 2050 von 11% auf 22% verdoppelt haben. In absoluten Zahlen bedeutet dies ein Anstieg von 605 Millionen auf 2 Milliarden Menschen [1-3].

Obwohl eine steigende Lebenserwartung generell eine positive Entwicklung für die Menschheit darstellt, bringt sie auch neue Herausforderungen mit sich. Diese basieren auf der Tatsache, dass das Älterwerden noch inhärent mit biologischer und kognitiver Degeneration verbunden ist, auch wenn Grad und Geschwindigkeit kognitiver Einschränkung, physischer Gebrechlichkeit und psychologischer Beeinträchtigung zwischen Individuen variieren kann.

Dennoch sind degenerative Alterungsprozesse die Hauptursache für nicht-übertragbare Krankheiten (non-communicable diseases – NCDs) wie Krebs, koronare Herzerkrankungen, Schlaganfall, Typ 2 Diabetes, die Alzheimer-Krankheit und weitere.

Neurodegenerative Erkrankungen, welche die mentalen Fähigkeiten einschränken, zählen zu den größten Ursachen für Behinderungen weltweit und sind für mehr als 20% der gelebten Jahre mit Behinderung verantwortlich.

Daher ist es notwendig, Anstrengungen auf die Minderung dieses Problems zu richten.

Gemäß des “Entwurfs des Zwölften Allgemeinen Arbeitsprogramms” (April 13, 2013) der Weltgesundheitsorganisation (WHO),  wird die “Adressierung der Herausforderungen nicht-übertragbarer Krankheiten” als eine Priorität der WHO genannt [4]. Die Adressierung des Alterns passt somit in die Definition des Anliegens und ist sogar notwendig, um dieses vorrangige Ziel zu erreichen.

Altern erhöht auch das Risiko der Morbidität und Mortalität durch Infektionskrankheiten wie Lungenentzündung und Grippe. Ebenfalls steigt die Anfälligkeit für Verletzungen und Traumata (z.B. durch Stürze und Stöße) aufgrund von Beeinträchtigungen des Gleichgewichtssinns und der mentalen Verfassung. Sogar die Gefahr, Opfer von Gewalt und Verbrechen zu werden steigt im Alter. Der Alterungsprozess verschärft und verstärkt auch die negativen Wirkungen anderer Risikofaktoren nicht-übertragbarer Erkrankungen (Tabakkonsum, ungesunde Ernährung, mangelnde physischer Aktivität und Alkoholmissbrauch).

In der Summe ist die altersbedingte Gesundheitsabnahme die Hauptursache für Mortalität und Morbidität weltweit und sollte entsprechend der Schwere dieses Problems angegangen werden.

Aufgrund dieser weitreichenden und negativen Auswirkungen gilt Altern bereits als eine der größten wirtschaftlichen und gesellschaftlichen Herausforderungen, mit denen sich fast alle Länder – insbesondere aber die industrialisierten Regionen – in Zukunft konfrontiert sehen.

Viele Berichte der nationalen Regierungen, internationalen Organisationen wie den Vereinten Nationen (UN) und der Weltgesundheitsorgani-sation (WHO), Wohlfahrtsorganisationen und Nicht-Regierungsorganisationen (NGO) thematisieren bereits die sozioökonomischen und gesundheit-lichen Herausforderungen der alternden Gesellschaft [5-9]:

  • Das Problem des Anstiegs der Gesund-heitskosten und die finanzielle Belastung der Sozialsysteme wegen der zunehmenden Wahrscheinlichkeit, an altersbedingten Krankheiten zu leiden.
  • Die große Problematik der Demenz-erkrankungen, da hierfür zusätzliche intensive Pflege notwendig ist, die eine hohe Belastung für pflegende Angehörige und erhebliche Zusatzkosten mit sich bringt.
  • Der Rückgang aktiver Arbeitskräfte, insbes. in  hoch industrialisierten Ländern. Auch wenn diese Menschen länger im Berufsleben bleiben möchten, werden sie hierzu evtl. aufgrund altersbedingter physischer und kognitiver Beeinträchti-gungen nicht mehr in der Lage sein.
  • Die steigende Zahl der Senioren muss finanziert werden, während ein immer größerer Teil der arbeitenden Bevölkerung bezahlbare Pflege bereitstellen muss.

Es bestehen erhebliche Bedenken über die Lebens- und Gesundheitsqualität der älteren Bevölkerung aufgrund altersbedingter Erkrankungen, biologischer Degeneration und dem erhöhten Risiko, schwerwiegenden chronischen und lebensbedrohlichen Krankheiten zu erliegen.

Eine generelle Verminderung der Lebensqualität hindert ältere Menschen daran, ein erfülltes soziales, kulturelles und intellektuelles Leben zu führen.

Die Herausforderungen der alternden Gesellschaft werden weltweit erkannt und eine Vielzahl von Forschungs- und Entwicklungsprogrammen wurden weltweit initiiert, um altersbedingte Erkrankungen zu bekämpfen. Beispiele sind Kampagnen zur Prävention der Alzheimer-Krankheit und/oder das Diabetes-Vorsorgeprogramm der WHO, sowie die Entwicklung von Pflegetechnologien, z.B. Pflegeroboter, Sturzdetektoren,  Umgebungsunterstütztes Leben (AAL) und Infrastrukturverbesserungen für Barrierefreiheit.

Obwohl diese Anstrengungen lobenswert und verständlich sind, stellen sie dennoch punktuelle und lediglich ad hoc Lösungen dar, die der Dringlichkeit des Problems nicht hinreichend gerecht werden.

Insbesondere lösen Herangehensweisen wie Assistenztechnologien oder die Verbesserung von Pflege und Palliativmedizin nicht das ursächliche Problem der altersbedingten biologischen Degeneration. Die medizinische Forschung und Entwicklung ist derzeit immer noch hauptsächlich auf einzelne Krankheiten fokussiert, wie bspw. Alzheimer-Demenz, Herzerkrankungen, Osteoporose, Diabetes, Krebs etc. Der zugrundeliegende degenerative Alterungsprozesse als maßgebliche Ursache für diese Erkrankungen wird jedoch oftmals vernachlässigt.

Während der degenerative Alterungsprozess eine behindernde und schwächende Entwicklung darstellt, der z.B. die Anhäufung struktureller Schäden und eine Beeinträchtigung der Stoffwechselbalance mit sich bringt, stellt das Erreichen eines gesunden langen Lebens, gekennzeichnet durch die Aufrechterhaltung der Funktionsfähigkeit und Robustheit, seine Heilung dar.

Einige Effekte degenerierender Alterungsprozesse können durch soziale und wirtschaftliche Faktoren, sowie durch Lebensweisen (Ernährung, Bewegung, etc.) beeinflusst werden, jedoch nur in einge-schränktem Umfang. Daher ist es notwendig, die Erforschung der Biologie des Alterns und alterungsbedingter Krankheiten zu fördern, um die Gesundheit der alternden Bevölkerung wesentlich und nachhaltig zu verbessern.

Neue Richtungen in Forschung und Entwicklung verfolgen ganzheitliche Ansätze, um degenerative Prozesse und negative biologische Effekte des menschlichen Alterns zu verstehen. Sie adressieren mehrere fundamentale Hauptursachen des Alterns und altersbedingter Erkrankungen zusammen in einer miteinander verknüpften Weise.

So wurden z.B. bei der Geroscience Konferenz der US Gesundheitsbehörde (NIH) im Jahr 2013 die folgenden Forschungsschwerpunkte identifiziert: Anpassung an Stress, Epigenetik, Entzündungen, makromolekulare Schäden, Stoffwechsel, Proteostase, und Stammzellen/Regeneration [10,11]. Ebenfalls gibt es einige andere Beispiele für ähnliche Ansätze, welche die Erforschung wichtiger Gruppen von Alterungsprozessen priorisieren [12-17]. Anstatt einzelne Alterserkrankungen zu adressieren, werden dabei die Mechanismen des Alterungsprozesses selbst analysiert, mit dem Ziel, Möglichkeiten zur Intervention und Prävention zu finden.

Solche Ansätze sind aus den folgenden Gründen sehr vielversprechend:

  • Sie werden bereits von wissenschaftlichen Machbarkeitsstudien gestützt, welche die Erhöhung der gesunden Lebensspanne in Tiermodellen belegen und neue technologische Möglichkeiten für Eingriffe in grundlegende Alterungsprozesse demonstrieren [12,18-23].
  • Sie bieten Lösungen für eine Vielzahl nicht-übertragbarer, altersbedingter Krankheiten, sofern  diese stark durch degenerative Altersprozesse verursacht werden (z.B. chronische Entzündungen,Vernetzung von Makromolekülen, somatische Mutationen, Verlust von Stammzellpopulationen etc.)  [2428].
  • Darüber hinaus tragen die Lösungen wahrscheinlich auch zur Verringerung der Anfälligkeit älterer Menschen für übertragbare Krankheiten bei, da ihre Immunität verbessert wird. [29].

Die angewandten Ergebnisse solcher Forschung,  ihre Entwicklungen und Innovationen werden nachhaltige Lösungen für eine Vielzahl altersbedingter medizinischer und gesellschaftlicher Herausforderungen bieten, die globale Anwendung finden können.

Diese Art der Forschung und Entwicklung sollte schon aus ethischen Gründen unterstützt werden, um gleiche Gesundheitschancen für ältere und jüngere Menschen bieten zu können.

Es ist deshalb die gesellschaftliche Pflicht, insbesondere für Fachkräfte in Biologie, Medizin, Gesundheitswesen, Wirtschafts- und gesellschaftspolitischen Organisationen, sich dringend für höhere Investitionen zur Forschung und Entwicklung einzusetzen, die sich mit dem besseren Verständnis der Mechanismen des menschlichen biologischen Alterungsprozesses befasst, um diese Erkenntnisse in sichere, bezahlbare und universell verfügbare angewandte Technologien und Behandlungen umzusetzen.

Eine Priorisierung und Beschleunigung der Forschung und Entwicklung auf den folgenden Gebieten kann enorme Vorteile für die Gesellschaft, Wirtschaft und generelle Lebensqualität mit sich bringen:

  • Regenerative Medizin – einschließlich der Entwicklung von Stammzelltechnologien und verbundenen Produkte; in vivo und ex vivo Regeneration von Organen und Geweben; kontrollierter Zelltod; Immuno-Eliminierung von alternden Zellen oder Krebszellen.
  • Tissue Engineering – Kultivierung und Herstellung unterschiedlicher vaskulärer und nicht-vaskulärer Gewebe und  Ersatzorgane, bspw. durch Anwendung von 3D-Gewebedruck, biologisch abbaubaren Gewebe-Gerüsten, Bioreaktoren oder Mechanismen der Selbstorganisation.
  • Regulierung der gesamten Körperhomöostase, einschl. Regulierung des zirkadianen Rhythmus, neurohumoralen und molekularen Bioregulatoren.
  • Geroprotektive Substanzen – z.B. antiglykämische Stoffe, Statine, Antigerinnungsmittel, Antioxidationsmittel, Hormon- und  Mitochondrien-Modulatoren, entzündungshemmende, probiotische und bioregulierende Medikamente.
  • Entgiftung auf zellulärer und molekularer Ebene – z.B.: Chelatoren, Enterosorbenten, Moleküle um AGE aufzubrechen, oxidoreduktive Depolymerisation, Immuno-Clearance, enzymatische Clearance etc.
  • Nahrungsergänzung – Ermittlung des diätetischen Nährstoffbedarfs für ältere Menschen und über den gesamten Lebensverlauf, wie z.B. durch Verwendung von Nahrungsergänzungsmitteln mit Vitaminen, Spurenelementen, Moleküle für den intrazellulären Energiestoffwechsel etc.).
  • Gentherapie und Genmodulation – z.B. sichere Gentechnik, epigenetische und pharmakologische Stimulation der “Langlebigkeitsgene” (z.B.: Sirtuine und FOXO), Dämpfung von “Decay Accelerating Factors” (DAF), Beeinflussung langlebigkeitsfördernder genetischer Signalwege (z.B.: des mTOR-Signalwegs), Stimulation der Telomerase-Aktivität, RNA-Interferenz, genetische und epigenetische Sequenzierung und Screening für Langlebigkeitsfaktoren.
  • Nanomedizin – z.B. Nanopartikel zum Wirkstofftransport, neue Prototypen für künstliche Immunität und Sauerstoffversorgung, Mikro- und Nano-Technologien; Mittel für eine potenzielle makromolekulare Gewebereparatur.
  • Künstlicher Organersatz und elektrophysiologische Schnittstellen und Stimulation – z.B. funktionelle Prothesen für Organe und Gliedmaßen,  Neuroprothesen, erweiterte Gehirn-Computer-Schnittstellen, elektrophysiologische Stimulation beeinträchtigter Neuro- und Muskelfunktionen.
  • Selbstquantifizierung – eine umfassende Selbstüberwachung und personalisierte Diagnose von Vitalparametern und altersbedingten Faktoren, Berechnungen für eine ausgewogene und gesunde Ernährung sowie physische Aktivität für Ältere.
  • Data Mining – umfangreiche  Gesundheitsdatenanalysen; die Aufdeckung wirksamer Behandlungsansätze; formale und quantitative sowie visuell-gestützte und interaktive Modellierung von Alterungsprozessen, Krankheiten und Interventionen für die Verlangsamung degenerativer Alterungsprozesse.
  • Kryokonservierung und chemische Konservierung – nützlich für Organ- oder Gewebetransplantationen und für vertiefte Einblicke in die Physiologie des Alterns.

Die Behandlung von altersbedingten degenerierenden Prozessen mit Hilfe von biomedizinischen Methoden sollte zum neuen leistungsfähigen Ansatz und medizinischen Standard zur Prävention nicht-übertragbarer Krankheiten werden, welche Menschen in ihren späten Lebensjahren treffen. Der präventive medizinische Ansatz trägt maßgeblich zum Erhalt der Gesundheit älterer Menschen bei und verhindert funktionale Verschlechterungen.

Regierungen sollten die Schaffung und Umsetzung von Richtlinien sicherstellen, die der Forschungsförderung auf den Gebieten der biologischen Altersforschung und Erforschung altersbedingter Krankheiten dienen, um eine globale Verbesserung der Gesundheit älterer Menschen zu ermöglichen:

  1. Finanzierung:

Gewährleistung einer signifikanten Erhöhung der staatlichen und nicht-staatlichen Mittel für zielgerichtete (translationale) Forschung zur Verhinderung von degenerativen Alterungsprozessen, den damit verbundenen chronischen, nicht-übertragbaren Krankheiten und Behinderungen sowie für die Verlängerung der gesunden Lebensspanne.

Im Einzelnen:

  • Bereitstellung eines ausgewiesenen Prozentsatzes der Haushaltsgelder zuständiger Ministerien, z.B. Ministerium für Gesundheit oder Forschung und Entwicklung, v.a. in den Bereichen mit Zuständigkeit für die Erforschung und Behandlung von nicht-übertragbaren chronischen Erkrankungen.
  • Einsatz eines bestimmten Prozentsatzes der Gewinne kommerzieller Pharma-, Biotech- und Medizintechnikunternehmen für diesbezügliche Forschung und Entwicklung.
  • Gründung relevanter Forschungsstipen-dienprogramme auf wettbewerblicher sowie zielgerichteter Basis.
  • Eine Verdoppelung der Finanzierung für diese Forschung alle 5 Jahre für die nächsten 20 Jahre.

 

  1. Anreize:

Entwicklung und Implementierung rechtlicher und regulatorischer Rahmenbedingungen zur Schaffung von Anreizen für zielorientierte Forschung und Entwicklung zur spezifischen Adressierung von Entwicklung, Registrierung, Verwaltung und Verfügbarkeit von Medikamenten, Technologien und Therapien zur Verbesserung von Alterungsprozesses, altersbedingten Krankheiten und gesunder Langlebigkeit.

Im Einzelnen:

  • Entwicklung von Kriterien für eine wissen-schaftliche Evaluierung der Wirksamkeit und Sicherheit geroprotektiver Therapien.
  • Erleichterung von Testverfahren in silico und im Tiermodell sowie für ethische und sichere Studien solcher Therapien am Menschen.
  • Bereitstellung und Sicherstellung geroprotektiver Therapien im Status als Hilfsmittel und lebensverlängernde Therapie.
  • Die Verkürzung der Genehmigungs-verfahren für Therapien mit hohem Wirksamkeitsnachweis in präklinischen und frühen klinischen Studien sowie ihre Anwendung in Fällen weit fortgeschrittener Degeneration und aussichtsloser Prognosen.
  • Erteilung besonderer Anerkennung, Status und Vorteilen für gewerbliche und öffentliche Einrichtungen die auf diesen Gebieten in Forschung und Entwicklung tätig sind.
  1. Institutionen:

Auf- und Ausbau nationaler und internationaler Koordinierungs- und Beratungsstrukturen, Programmen und Institutionen, zur Förderung von Forschung, Entwicklung und Bildung zur Biologie des Alterns und damit verbundenen Krankheiten. Ebenso wie die Entwicklung von klinischen Leitlinien zur Modulation von Alterungsprozessen und den damit verbundenen alterungsbedingten Krankheiten zur Erhöhung der gesunden Lebensspanne der Bevölkerung.

Im Einzelnen:

  • Einführung von spezialisierten Kursen zur Biogerontologie als integraler Bestandteil der universitären Lehre und Forschung.
  • Entwicklung und Verbreitung geroprotektiver Therapien, basierend auf bestmöglicher vorhandener wissenschaftlicher Evidenz als Teil verbindlicher Gesundheitsempfehlungen.
  • Schaffung von kooperativen Exzellenzzentren für Grundlagen-, Translations- und Anwendungsforschung, zusammen mit Zentren für strategische Analyse, Prognose, Bildung und Policy-Entwicklung für Alters- und Langlebigkeitsforschung an akademischen Institutionen sowie nationalen und internationalen Regierungsorganisationen.

Diese Maßnahmen dienen dazu, die durch den Alterungsprozess entstehende wirtschaftliche Belastung zu minimieren und die Belastungen des Alterns und der beteiligten Angehörigen zu mindern.

Positiv gesehen können die Maßnahmen, bei hinreichender Förderung, zur Erhöhung der gesunden Lebensspanne älterer Menschen beitragen, die Zeitspanne ihrer Produktivität und sozialen Interaktion erhöhen sowie zur Verbesserung ihrer Lebensfreude, ihres Lebenssinns, der Chancengleichheit und des Lebenswerts beitragen.

 

 

 

 

Referenzen:

[1] World Health Organization (2014). World Health Statistics – Large Gains in Life Expectancy – Abgerufen im Dezember 2014 von: http://www.who.int/mediacentre/news/releases/2014/world-health-statistics-2014/en/. [Zitiert in: 1]

[2] Human Mortality Database – Abgerufen im Dezember 2014 von: http://www.mortality.org. [Zitiert in: 1]

[3] United Nations Department of Economic and Social Affairs, Population Division (2011). World Population Prospects: The 2010 Revision, CD-ROM Edition – Abgerufen im Dezember 2014 von: http://esa.un.org/wpp/. [Zitiert in: 1]

[4] World Health Organization (2013). Entwurf des 12. Allgemeinen Arbeitsprogramms – Abgerufen im Dezember 2014 von: http://www.who.int/about/who_reform/programme_priority/en/. [Zitiert in: 1]

[5] World Health Organization (2014). Ageing and Life Course – Abgerufen im Dezember 2014 von: http://www.who.int/ageing/en/. [Zitiert in: 1]

[6] United Nations Department of Economic and Social Affairs, Population Division (2013). World Population Aging Report – Abgerufen im Dezember 2014 von: http://www.un.org/en/development/desa/population/. [Zitiert in: 1]

[7] The International Longevity Center Global Alliance (2010). Global Aging Report. Threats to Longevity. A Call to Action – Abgerufen im Dezember 2014 von: http://www.ilc-alliance.org/index.php/reports/. [Zitiert in: 1]

[8] Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V(2012). Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 380: 2095-2128 [Zitiert in: 1] [JCR: 39.06]

[9] Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H(2012). A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010 a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 380: 2224-2260 [Zitiert in: 1] [JCR: 39.06]

[10] Kennedy BK, Berger SL, Brunet A, Campisi J, Cuervo AM, Epel ES (2014). Geroscience: linking aging to chronic disease. Cell, 59: 709-713 [Zitiert in: 1] [JCR: 31.957]

[11] Healthspan Campaign (2013). NIH Geroscience Interest Group (GSIG) Releases Recommendations from the October 2013 Advances in Geroscience Summit – Abgerufen im Dezember 2014 von: http://healthspancampaign.org/2014/02/27/nihgeroscience-interest-group-gsig-releases-recommendations-october-2013-advances-geroscience-summit/ [Zitiert in: 1]

[12] Fahy GM, West MD, Coles LS, Harris SB – The Future of Aging: Pathways to Human Life Extension – New YorkSpringer2010 [Zitiert in: 2]

[13] Fontana L, Kennedy BK, Longo VD, Seals D, Melov S (2014). Medical research: treat ageing. Nature, 511: 405-407 [Zitiert von: 1] [JCR: 38.597]

[14] López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G(2013). The hallmarks of aging. Cell, 153: 1194-1217 [Zitiert von: 1] [JCR: 31.957]

[15] De Grey ADNJ, Rae M Ending Aging. The Rejuvenation Breakthroughs That Could Reverse Human Aging in Our LifetimeNew YorkSt. Martin’s Press2007 [Zitiert in: 1]

[16] Goldman DP, Cutler D, Rowe JW, Michaud PC, Sullivan J, Peneva D, Olshansky SJ(2013). Substantial health and economic returns from delayed aging may warrant a new focus for medical research. Health Aff, 10: 1698-1705 [Zitiert in: 1]

[17] Rae MJ, Butler RN, Campisi J, de Grey ADNJ, Finch CE, Gough M(2010). The demographic and biomedical case for late-life interventions in aging. Sci Transl Med, 2: 40cm21 [Zitiert von: 1] [JCR: 10.757]

[18] Kanfi Y, Naiman S, Amir G, Peshti V, Zinman G, Nahum L(2012). The sirtuin SIRT6 regulates lifespan in male mice. Nature, 483: 218-221 [Zitiert in: 1] [JCR: 38.597]

[19] Atala A Extending life using tissue and organ replacement. 2008). Curr Aging Sci, 1: 73-83 [Zitiert in: 1]

[20] Baati T, Bourasset F, Gharbi N, Njim L, Abderrabba M, Kerkeni A(2012). The prolongation of the lifespan of rats by repeated oral administration of [60] fullerene. Biomaterials, 33: 4936-4946 [Zitiert in: 1] [JCR: 7.604]

[21] Kheir JN, Scharp LA, Borden MA, Swanson EJ, Loxley A, Reese JH(2012). Oxygen gas-filled microparticles provide intravenous oxygen delivery. Sci Transl Med, 4: 140ra88 [Zitiert in: 1] [JCR: 10.757]

[22] Shawn M, Douglas SM, Bachelet I, Church GM (2012). A logic-gated nanorobot for targeted transport of molecular payloads. Science, 335: 831-834 [Zitiert in: 1]

[23] Kennedy BK, Pennypacker JK (2014). Drugs that modulate aging: the promising yet difficult path ahead. Transl Res, 163: 456-465 [Zitiert in: 1] [JCR: 3.49]

[24] Chung HY, Cesari M, Anton S, Marzetti E, Giovannini S, Seo AY(2009). Molecular inflammation: Underpinnings of aging and age-related diseases. Ageing Res Rev, 8: 18-30 [Zitiert in: 1] [JCR: 5.953]

[25] Lunn JS, Sakowski SA, Hur J, Feldman EL (2011). Stem cell technology for neurodegenerative diseases. Ann Neurol, 70: 353-361 [Zitiert in: 1] [JCR: 11.193]

[26] Baylis D, Bartlett DB, Patel HP, Roberts HC (2014). Understanding how we age: insights into inflammaging. Longev Healthspan, 3: 6 [Zitiert in: 1]

[27] Dai DF, Chiao YA, Marcinek DJ, Szeto HH, Rabinovitch PS (2014). Mitochondrial oxidative stress in aging and healthspan. Longev Healthspan, 3: 6 [Zitiert in: 1]

[28] Zieman S, Kass D (2004). Advanced glycation end product cross-linking: Pathophysiologic role and therapeutic target in cardiovascular disease. Congest Heart Fail, 10: 144-149 [Zitiert in: 1]

[29] Bredenkamp N, Nowell CS, Blackburn CC (2014). Regeneration of the aged thymus by a single transcription factor. Development, 141: 1627-1637 [Zitiert in: 1] [JCR: 6.208]

170-летие Ильи Ильича Мечникова – основателя геронтологии – 15 Мая 2015

mechnikov 15 Мая, 2015 года является 170-й годовщиной со дня рождения основателя научных исследований старения и долголетия – Ильи Ильича Мечникова (15 Мая, 1845 – 15 Июля, 1916). Для сторонников здорового долголетия и исследований старения и продления жизни, годовщина дня рождения Мечникова имеет особое значение. Мечников, разумеется, известен как один из крупнейших иммунологов и микробиологов, как заместитель директора Института Пастера в Париже, как лауреат Нобелевской премии по физиологии и медицине за 1908 год за открытие фагоцитоза, внесшее решающий вклад в развитие клеточной теории иммунитета. Тем не менее, его можно по праву считать «отцом» геронтологии — дисциплины, для которой он впервые предложил название. Как термин «геронтология» («научное изучение старости»), так и термин «танатология» («научное изучение смерти») были изначально предложены им в книге «Этюды о природе человека», впервые опубликованной в 1903 году, и знаменующей основание этих научных дисциплин. До сегодняшнего дня Мечников сохраняет высочайшую научную репутацию во всем мире, в особенности в русскоязычном мире. По сути он является объединяющим культурным символом для русских, украинцев, молдаван, евреев, многих других исторически связанных народов.

Мечников является либо первооткрывателем, либо одним из первых исследователей многих ключевых направлений исследований старения и продления жизни, положив начало научным программам, продолжающимся до наших дней. Среди них можно упомянуть по сути первую действительно научную системную теорию старения и долголетия, основанную на скрупулезных гистологических наблюдениях и на модели динамическогофизиологического поведения живых тканей, в особенности показывающую роль иммунной системы (фагоцитов) и интоксикации кишечной микрофлоры (микробиома) в процессах старения. Мечников также внес основополагающий вклад в дискуссии эволюционной  теории старения, в частности относительно возможности «запрограммированного» старения. Благодаря ему начали разрабатываться многие практические геропротекторные средства, такие как пробиотические диеты, системная и поддерживающая иммунотерапия (сывороточная терапия, в частности применение цитотоксических сывороток для стимуляции тканей), исследования заместительной терапии и регенерации.

Ввиду огромной значимости процессов старения для практически всех видов заболеваний, как инфекционных так и хронических неинфекционных, и в свете ускоряющегося создания все новых, более эффективных потенциальных средств вмешательства в процессы старения ради достижения здорового долголетия – вклад Мечникова в развитие этой области приобретает все большее мировое значение. Мир стремительно стареет, что грозит серьезными последствиями для глобального сообщества, в частности экономики. В то же время, стремительно развивающаяся биомедицинская наука и технология стоят на передовых линиях обороны от потенциальной угрозы. Эти две постоянно растущие силы выдвигают геронтологию, с одной стороны описывающую проблемы старения, с другой ищущую пути их решения, на центральные позиции мирового научного, технологического и политического обсуждения. В этот период необходимо отдать долг уважения Мечникову, стоявшему у истоков геронтологии, не только как научной области, но и как общественного и интеллектуального движения.

Существует традиция праздновать дни рождения и юбилеи великих людей (ученых, писателей, политиков, полководцев) для продвижения сфер их деятельности, для популяризации их идеологии. Можно выразить надежду, что в этом году юбилей Мечникова послужит для продвижения и популяризации науки и идеологии продления здоровой жизни, вплоть до государственного уровня. «День Мечникова» может послужить толчком для организации тематических встреч и конференций, стимулом для исследований, и публикаций СМИ, посвященных наследию Мечникова и продолжению дела его жизни – изучению старения и долголетия, что может сыграть позитивную роль не только в содействии и пропаганде исследований старения и здорового долголетия, но и послужить укреплению духа оптимизма, делу мира и сотрудничества.

Мероприятия (встречи и публикации) в честь Дня Мечникова были проведены в нескольких странах различными общественными и научными организациями, ратующими за развитие исследований старения и продления жизни, включая высокоавторитетные национальные ассоциации и научные центры.

Проведены были встречи и семинары – в Киеве, Украина, от Киевского Института Геронтологии Национальной Академии Медицинских Наук Украины; в Санкт Петербурге, Россия – под эгидой Геронтологического Общества Российской Академии Наук и Северо-Западного Государственного Медицинского Университета имени И.И. Мечникова; в Москве под эгидой Федерального Центра Профилактической Медицины Министерства Здравоохранения Российской Федерации, встречи в Москве также были проведены рядом общественных организаций, таких как Федоровское Движение, Российское Трансгуманистическое Движение и Российский Альянс за Продление Жизни. Также проводились семинары в Ларнаке, Кипр, от Фонда ЕЛПИ и Института Технологии и Нейронауки Кипра; в Оксфорде, Англия, под эгидой Научного Общества Университета Оксфорд и Фонда Биогеронтологических Исследований; в Рамат Гане, Университет Бар Илан, Израиль, под эгидой Израильского Альянса за Продление Жизни и Международного Общества по изучению Старения и Болезней (Израильское отделение).

Можно надеяться, что, следуя этим примерам, будут организовываться дополнительные встречи и публикации для популяризации исследований старения и долголети, приуроченные к этому дню или близлежащим. Так, благодаря авторитету Мечникова, удастся усилить интерес в жизненно важной теме исследований старения и долголетия во всех слоях общества,  включая широкую общественность, профессиональное и научное сообщество, и руководство,

Др. Илья Стамблер.

Координатор по общественным связям. Международное Общество по изучению Старения и Болезней – International Society on Aging and Disease (ISOAD)

Отделение Науки, Технологии и Общества. Университет Бар Илан, Рамат Ган. Израиль

http://www.longevityhistory.com/

www.isoad.org

ilia.stambler@gmail.com

Конференции, посвященные юбилею Мечникова :

Москва. Май 13-15. «Основы современного управления болезнями старения и программа “Забота”. Государственный научно- исследовательский центр профилактической медицины Минздрава РФ.

http://www.longevityforall.org/care-conference-and-170th-metchnikoff-anniversary/

Санкт Петербург. “3-я научно-практическая конференция молодых ученых «Трансляционная медицина: от теории к практике», посвященная 170-летию со дня рождения Ильи Ильича Мечникова, 22 апреля 2015 г”. Северо-западный Государственный Медицинский Университет имени И.И. Мечникова.

http://szgmu.ru/rus/m/2116/

Киев. Украина. Институт Физиологии им. Богомольца https://www.facebook.com/events/951327664917383/ 

Рамат Ган. Университет Бар Илан. Израиль https://www.facebook.com/events/699281383528706/

Оксфорд. Англия. Научное Общество Университета Оксфорд https://www.facebook.com/OUSciSoc

Ларнака. Кипр. Дом Литературы и Искусств http://www.elpisfil.org/page5.htm

 

Общая группа на фейсбуке, посвященная юбилею: https://www.facebook.com/events/651842968294070/

Страничка на фейсбуке, посвященная И.И. Мечникову: https://www.facebook.com/Elie-Metchnikoff-986904764707513/?fref=ts